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CHAPTER 1 
DYNAMIC INTERFACE IMPRINTING: HIGH AFFINITY PEPTIDE BINDING SITES 
ASSEMBLED BY ANALYTE-INDUCED RECRUITING OF MEMBRANE 
RECEPTORS 
 
 
Dynamic molecular recognition events at biological membrane receptors play a key role in 
cell signaling. We have prepared artificial membranes with embedded synthetic receptors 
which dynamically arrange and selectively respond to external stimuli like small peptide 
ligands. 
 
 
This Chapter has been published: 
B. Gruber, S. Balk, S. Stadlbauer, B. König, Angew. Chem. Int. Ed., 2012, 51, 10060–10063 (Hot 
Paper). 
Author contributions: 
BG performed binding studies and wrote the manuscript; SB synthesized compound Cu3 and 
performed FRET binding studies; SS synthesized compounds Cu4, Zn21, Zn22; BK supervised the 
project and is corresponding author. 
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Introduction 
Molecular recognition between membrane-associated receptors and external ligands as 
stimuli is important for many biological processes.1-3 The dynamic formation of domains 
and the clustering of receptors in fluid membranes play a key role e.g. in signal trans-
duction leading to highly specific binding of competing multivalent ligands.4-6 
 
Scheme 1. Structures of synthetic receptors and ligands (counterions omitted). 
Various model systems for biological membranes have been developed to understand 
and mimic multivalent interactions at interfaces7-12 as well as for applications in delivery, 
sensing and catalysis.13-18 The principle of template-guided assembly has also been 
extensively exploited in molecular imprinting,19, 20 but the non-covalent arrangement of 
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binding sites in precisely defined distances still remains a challenge. We have 
investigated a concept that mimics immunological synapses, where receptors are 
recruited at a membrane interface, spatially organized by the binding partner and this 
orientation triggers a specific response.21-23 Our vesicles with membrane-embedded 
luminescent receptors produce a characteristic optical response in the presence of small 
peptides as external ligands. Depending on the functional groups present in the peptide, 
suitable receptors with complementary binding sites are recruited and arranged in the fluid 
membrane, which triggers a FRET signal. 
 
Results and Discussion 
We have previously reported on the recognition of small biomolecules and phosphorylated 
proteins by multi-site interactions24, 25 at the lipid-water interface using synthetic vesicle 
membranes with embedded artificial receptors based on transition metal complexes of 
1,4,7,10-tetraazacyclododecane (cyclen) and nitrilotriacetic acid (NTA). We now expand 
this concept to the dynamic recruiting of synthetic receptors allowing the multivalent 
recognition of phosphorylated peptides. The selective recognition of phospho-serine 
(pSer) and histidine (His) moieties in model-peptide P1 by metal-complex binding sites 
was investigated in a previous study in homogeneous solution.26 It was found that in 
buffered aqueous solution Zn(II)-cyclen receptor Zn26 binds peptide P1 with log K = 4.8, 
while dimer Zn46, allowing a simultaneous two-prong interaction to pSer and His, shows 
an affinity of log K = 7.5 (see Table 1, entries 1 and 2 and Supporting Information). 
Instead of covalently connecting two receptor sites, as in Zn46, distinct binding sites are 
now simply embedded in synthetic lipid bilayers. Recruiting and self-organization by the 
peptide ligand allows the divalent binding of both pSer and His residues of P1 at the 
membrane interface. 
First we embedded Zn25 (1 mol%) in vesicular lipid bilayers from 1,2-distearoyl-sn-
glycero-3-phosphocholine (DSPC) using previously reported procedures (see Supporting 
Information). The emission intensity of peptide P1 increases significantly upon binding to 
the surface receptors (see SI) and a binding constant of log K = 5.9 (Table 1, entry 3) at 
ambient temperature was derived. This value is in good agreement with the recognition of 
pSer by a single Zn25 receptor
24 and reasonable, because DSPC’s high phase transition 
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temperature (54 °C)27 restricts diffusion and thus participation of more than a single metal 
complex binding site in the peptide recognition (cf. Figure 1, Top). Binding affinities could 
only be enhanced by drastically increasing the vesicle receptor loading to 10 mol% 
(Table 1, entry 4) resulting in the formation of tightly packed metal complex patches.16 
However, replacing the saturated DSPC lipid by unsaturated 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC), which has a much lower transition temperature of -20 °C,27 
leads to an increase in peptide P1 binding affinity by more than two orders of magnitude 
(Table 1, entry 5). The embedded receptor sites can now diffuse in the membrane at room 
temperature allowing complex formation of one P1 with two Zn25 units by a dynamic 
assembly process (Figure 1, Top). Unchanged particle sizes determined by dynamic light 
scattering (Supporting Information, Figure S11) confirm binding of the peptide to receptors 
of one vesicle (intra-membrane binding mode) and excludes peptide crosslinking of 
different vesicles (inter-membrane binding). 
Entry Lipid Receptor Mol% log K 
1 - Zn26 - 4.8
 [a]
 
2 - Zn46 - 7.5
 [a]
 
3 DSPC Zn25 1 5.9 
4 DSPC Zn25 10 8.1 
5 DOPC Zn25 1 8.6 
6 DSPC Zn22 1 6.2 
7 DSPC Cu4 1 5.0 
8 DSPC Zn22 + Cu4 1 (each) 6.3 
9 DOPC Zn22 1 5.5 
10 DOPC Cu4 1 5.8 
11 DOPC Zn22 + Cu4 1 (each) 8.8 
 
Table 1. Summary of apparent binding constants for peptide P1 by synthetic receptors in 
homogeneous solution (entry 1 and 2) and embedded in vesicle membranes (HEPES buffer, 
pH 7.4, 25 °C). 
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The experiments show that analyte induced recruiting of binding sites in a fluid membrane 
leads to higher binding affinities due to multipoint interaction. Next, vesicle membranes 
with two different embedded receptors, which bind selectively either pSer or His of P1, 
were investigated. The synthesis of amphiphilic Cu(II)-NTA complex Cu4 for the 
recognition of histidine was reported previously,24 the synthesis of the amphiphilic Zn(II)-
3,5-bis-[(bis-pyridin-2-ylmethyl-amino)-methyl]-4-hydroxy-phenyl (DPA) complex Zn22 for 
the selective recognition of phosphate28 is described in the Supporting Information. Stable 
metal complex-doped DOPC and DSPC vesicle membranes were prepared using Zn22 or 
Cu4 and a mixture of both (1 mol% each). For DSPC membranes with one type of 
receptor embedded the emission titrations with P1 revealed monovalent binding either to 
Zn-DPA or to Cu-NTA coordination,29 with log K = 5.0 and 6.2, resp. (Table 1, entries 6 
and 7). Job’s plots with P1 as limiting reagent confirm the 1:1 stoichiometry of the binding 
event (Figure S18). Combining both receptors in gel-phase DSPC-membranes (Figure 1, 
Bottom) does not increase the binding affinity for peptide P1 (log K = 6.3; Table 1, entries 
6, 7, 8). The binding isotherm for the receptor vesicles bearing both complexes resembles 
the average of the binding properties of the individual receptor vesicles (see SI for data). 
This is explained by a random, but fixed position of lipid bilayer embedded metal complex 
receptors, which prevents the formation of a ternary Zn22-P1-Cu4 complex (see SI for 
Job´s plots). DOPC membranes, in contrast, show a completely different behaviour: 
Whereas vesicles with either Zn22 or Cu4 as embedded receptors give similar binding 
isotherms and affinity constants (log K = 5.5 and 5.8, resp.; Table 1, entries 9, 10), the 
liquid-crystalline membrane containing both receptor binding sites shows a significantly 
higher affinity for peptide P1 in the nanomolar range (log K = 8.8, Table 1, entry 11 and 
Figure 1, Bottom). We explain this by the divalent binding of P1 by a heterodimeric Zn2- 
and Cu-receptor assembly in the fluid lipid bilayer (cf. Figure 1, Bottom) resulting from 
peptide induced self-organization of the membrane receptors. The Job’s plot analysis 
(Figure S19) supports this conclusion.    
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Figure 1. (Top) Schematic receptor assembly in vesicle membranes: Fixed receptors in gel-phase 
DSPC-membranes vs. analyte-induced clustering in fluid DOPC-membranes; (Bottom) Emission 
titrations of P1 vs. DSPC and DOPC- membranes containing Zn21, Cu3 or both receptors. 
For bioanalytical applications, the labeling of the peptide analyte must be avoided. 
Therefore amphiphilic receptor binding sites that signal the presence of the target analyte 
by induced FRET were developed: Zn(II)-DPA complex (Zn21) is labeled with 
carboxyfluorescein (FAM) and Cu(II)-NTA complex Cu3 is rhodamine (TMR) labeled. 
FRET techniques are widely used in molecular biology to measure distances within bio-
molecules or to explore membrane structures.30 We use the FRET signal, which is 
induced by the close distance of the membrane-embedded luminescent binding sites to 
signal the presence of peptide P2, which in contrast to P1, does not carry a fluorescent 
label. Divalent binding of P2 to the membrane embedded binding sites recruits Zn21 and 
Cu3 into close proximity and therefore within the Förster distance of 5.5 nm31 resulting in a 
FRET signal as optical output (Figure 2, Top).32 
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The vesicles responded to the presence of the target peptide P2 with a significant FRET-
signature. Formation of a Zn21-P2-Cu3 ternary complex leads to energy transfer of the 
donor label FAM at 490 nm to the acceptor label TMR at 580 nm (Figures 2, Bottom and 
S22). However, an excess of the target peptide is necessary to reach the maximum 
energy transfer. Control experiments with monovalent ligands (PP, PH and P0) did not 
change the observed emission spectra significantly (Figure S23). We exclude inter-
vesicular FRET via crosslinking of distinct vesicles as the solution particle size remains 
unchanged in the presence of P2 (Figures S24, 25). Additionally, vesicles were purified by 
size exclusion chromatography before binding experiments to remove traces of  
amphiphilic receptors or micellar aggregates from the solution and the concentrations of 
the embedded receptors were verified by Zn- and Cu-element analysis using ICP-AES 
(see SI).33 
 
Figure 2. (Top) Schematic recruiting of labeled membrane receptors by a peptide ligand resulting 
in a FRET signal; (Bottom) Fluorescence spectra of DOPC vesicles containing labeled receptors 
Zn21 + Cu3 (1 mol% each) in the absence (red) and presence (green) of peptide P2. Relative 
FRET emission ratio (I580nm/I520nm) of P2 and monovalent PH and PP as control (inset). 
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As additional control experiments, DOPC and DSPC vesicles with only one of the two 
binding sites were prepared and used for emission titrations with increasing amounts of 
corresponding ligands (pSer/PP for Zn21 and His/PH for Cu3). As expected, no significant 
change in the optical properties of the fluorescent receptor-vesicles was observed 
(Figure S21). DSPC vesicles with both co-embedded receptors Zn21 and Cu3 (0.1 mol% 
each) show a small energy transfer between the FAM- and TMR-labels in the absence of 
the peptide ligand (Figure S20), which might be explained by the partial formation of 
Zn21/Cu3 heterodynes. Upon addition of any mono- or divalent ligand no change in 
emission was detected, as the gel-phase state of the DSPC membranes at room 
temperature limits the diffusion of the embedded metal complexes (Figure S22). 
 
Conclusion 
In conclusion, we demonstrated the specific recognition of peptides by dynamic interface 
imprinting of synthetic binding sites embedded in vesicle membranes. The amphiphilic 
metal complex binding sites are recruited in the membrane by the target peptide resulting 
in multivalent interactions and nanomolar binding affinity. The use of amphiphilic binding 
sites with FRET pair chromophores, leads to self-organization of a specific analyte epitope 
at the lipid-water interface and a FRET signal indicating the presence of the target 
analyte. 
The experimental data proof that dynamic binding site recruitment in fluid membranes by 
analytes (dynamic interface imprinting, DII) leads to the formation of high affinity epitopes. 
The process allows the specific detection of functional groups in peptides with nanomolar 
affinity. To further improve the sensitivity and selectivity of functionalized luminescent 
vesicles in chemical bioanalysis the number and nature of simultaneously embedded 
binding sites may be increased, including peptides or nucleotides as recognition moieties. 
The combined use of several chromophores in the membrane gives a specific 
spectroscopic output depending on their spatial arrangement. Such functionalized 
luminescent vesicles may in some applications replace antibody based assays. 
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Experimental Part and Supporting Information 
General methods and material 
Fluorescence measurements were performed with UV-grade solvents (Baker or Merck) in 
1 cm quartz cuvettes (Hellma) and recorded on a Varian ‘Cary Eclipse’ fluorescence 
spectrophotometer with temperature control. Absorption was recorded on a Varian Cary 
BIO 50 UV/VIS/NIR Spectrometer with temperature control by use of a 1 cm quartz 
cuvettes (Hellma) and Uvasol solvents (Merck or Baker). PCS measurements were 
performed on a Malvern Zetasizer Nano at 25 °C using 1 cm disposable polystyrene 
cuvettes (VWR). NMR spectra were recorded on Bruker Avance 600 (1H: 600.1 MHz, 
13C: 150.1 MHz, T = 300 K), Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 MHz, 
T = 300 K), Bruker Avance 300 (1H: 300.1 MHz, 13C: 75.5 MHz, T = 300 K). The chemical 
shifts are reported in  [ppm] relative to external standards (solvent residual peak). The 
spectra were analyzed by first order, the coupling constants are given in Hertz [Hz]. 
Characterization of the signals: s = singlet, d = doublet, t = triplet, q = quartet, 
m = multiplet, bs = broad singlet, psq = pseudo quintet, dd = double doublet, dt = double 
triplet, ddd = double double doublet. Integration is determined as the relative number of 
atoms. Assignment of signals in 13C-spectra was determined with DEPT-technique (pulse 
angle: 135 °) and given as (+) for CH3 or CH, (–) for CH2 and (Cq) for quaternary C. Error 
of reported values: chemical shift: 0.01 ppm for 1H-NMR, 0.1 ppm for 13C-NMR and 0.1 Hz 
for coupling constants. The solvent used is reported for each spectrum. Mass spectra 
were measured on Varian CH-5 (EI), Finnigan MAT 95 (CI; FAB and FD), Finnigan MAT 
TSQ 7000 (ESI) with Xenon as ionization gas for FAB. IR spectra were recorded on Bio-
Rad FTS 2000 MX FT-IR and Bio-Rad FT-IR FTS 155. Melting Points were determined on 
Büchi SMP or a Lambda Photometrics OptiMelt MPA 100. Thin layer chromatography 
(TLC) analyses were performed on silica gel 60 F-254 with a 0.2 mm layer thickness. 
Detection via UV light at 254 nm / 326 nm or through staining with ninhydrin in EtOH. 
Column chromatography was performed on silica gel (70–230 mesh) from Merck. 
Commercially available solvents of standard quality were used. Starting materials were 
used without any further purification. Phospholipids were purchased from Avanti Polar 
Lipids Inc. Commercially available solvents of standard quality were used. If not otherwise 
stated, purification and drying was done according to accepted general procedures.34 
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Elemental analyses were carried out by the Centre for Chemical Analysis of the Faculty of 
Chemistry and Pharmacy of the University of Regensburg. 
Synthesis of amphiphilic bis-Zn(II)-DPA complexes Zn21 and Zn22 
Receptor Zn21 and Zn22 were prepared from a tyrosine based bis-DPA metal chelating 
lipid which was synthesized according to a modified protocol of the procedure for the 
binuclear tyrosine based bis-DPA reported by Hamachi et al.35 Derivatization of the 
tyrosine scaffold on large scale was possible by standard peptide solution chemistry. 
 
Scheme S1a. Synthesis of amphiphilic tyrosine based bis-dpa zinc complexes. (a) Boc2O, DCM, 
RT, 20 h; (b) EDC, HOBt, DIPEA, DMF, toluene, 60 °C, 22h; (c) 2,2`-dipicoloylamine, 
paraformaldehyde, H2O, 
i
PrOH, 80 °C, 30 min, reflux, 17 h; (d) HCl / ether, DCM, RT, 16 h. 
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Scheme S1b. Synthesis of amphiphilic tyrosine based bis-dpa zinc complexes. (e) ZnCl2, MeOH, 
RT, 2 - 3 h; (f) 5/6-carboxyfluorescein, DIPEA, TBTU, HOBt, DMF, 40 °C, 22 h. 
Amide formation of 2536 with octadecylamine gave amphiphilic tyrosine derivative 26 in 
good yields. Mannich type reaction using 2,2`-dipycolylamine and paraformaldehyde 
according to literature known procedure gave the protected metal chelating lipid 27.35 
Removal of the Boc group in acidic conditions (HCl/ether) yielded compound 28 which 
was finally treated with two equivalents of ZnCl2 to give Zn22. 
A fluorescein label was introduced by amide formation of 28 with an isomeric mixture of 
5/6-carboxy fluorescein. Subsequent treatment with ZnCl2 gave the fluorescent 
amphiphilic binuclear tyrosine based metal complex Zn21. 
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[2-(4-Hydroxy-phenyl)-1-octadecylcarbamoyl-ethyl]-carbamic acid tert-butyl ester (26) 
Boc-Tyr-OH 25 (2.50 g, 8.9 mmol), DIPEA (5.0 mL, 29.3 mmol), EDC (1.73 mL, 
9.8 mmol), and HOBt (1.32 g, 9.8 mmol) were dissolved in DMF (4 mL) under ice cooling 
and stirred for 45 min. Subsequently a solution of octadecylamine (2.89 g, 9.8 mmol) in 
25 mL DMF was added slowly. The reaction was allowed to warm to room temp. and was 
stirred over night (22 h) at 60 °C. The reaction progress was monitored by TLC 
(CHCl3 / MeOH 9:1). After completion of the reaction the solvent was removed and the 
crude product was loaded on flash silica gel and purified by flash column chromatography 
(CHCl3 / MeOH 95:5, Rf = 0.40) yielding 26 (3.82 g, 7.2 mmol, 81 %) as a colourless solid. 
MP: 115 °C. – 1H-NMR (600 MHz; CDCl3):  (ppm) = 0.87 (t, 
3J = 7.0 Hz, 3 H, C28H3), 1.25 
(s, 30 H, C13H2 – C
27H2), 1.36 (bs, 2 H, COSY: C
12H2), 1.42 (s, 9 H, COSY: C
1H3), 2.83-
3.02 (m, 2 H, COSY: C5H2), 3.07-3.24 (m, 2 H, COSY: C
11H2), 4.21 (m, 1 H, HMBC, 
COSY: C4H), 5.17 (bs, 1 H, COSY: NHa), 5.91 (bs, 1 H, COSY: NHb), 6.74 (d, 2J = 8.5 Hz, 
2 H, HMBC: C8H), 7.02 (d, 2J = 7.7 Hz, 2 H, HMBC: C7H). – 13C-NMR (150 MHz; CDCl3):  
(ppm) = 14.1 (+, 1 C, C28H3), 22.7 (–, 1 C, alkyl-CH2), 26.8 (–, 1 C, alkyl-CH2), 28.3 (+, 3 
C, C1H3), 29.2 (–, 1 C, alkyl-CH2), 29.3 (–, 1 C, alkyl-CH2), 29.5 (–, 1 C, C
12H2), 29.60, 
29.65, 29.69 (–, 10 C, alkyl-CH2), 31.9 (–, 1 C, alkyl-CH2), 37.9 (–, 1 C, C
5H2), 39.6 (–, 1 
C, C11H2), 56.2 (+, 1 C, HMBC: C
4H3), 80.3 (Cq, 1 C, C
2), 115.6 (+, 2 C, HMBC: C7H), 
130.4 (+, 2 C, HMBC: C8H), 128.1 (Cq, 1 C, HMBC: C
6), 155.2 (Cq, 1 C, HMBC: C
9), 155.6 
(Cq, 1 C, HMBC: C
3), 171.3 (Cq, 1 C, HMBC: C
10). – IR (ATR) [cm-1]: 
~
 [cm] = 3335, 3306, 
2959, 2917, 1682, 1655, 1523, 1468, 1367, 1295, 1236, 1168, 1046, 896, 799. – MS 
(ESI(+), DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 533.6 (100) [MH
+], 477.4 (19) [MH+ - 
C4H8]
+, 555.5 (36) [MNa+]. – Elemental analysis calcd. (%) for C32H56N2O4: C 72.14, H 
10.59, N 5.26; found C 72.13, H 10.63, N 5.00. – MF: C32H56N2O4 – FW: 532.81 g/mol. 
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(2-{3,5-Bis-[(bis-pyridin-2-ylmethyl-amino)-methyl]-4-hydroxy-phenyl}-1-octadecyl 
carbamoyl-ethyl)- carbamic acid tert-butyl ester (27) 
2,2’-Dipicolylamine (2.35 g, 11.8 mmol) and paraformaldehyde (0.56 g, 18.9 mmol) were 
dissolved in 30 mL water / isopropanol (5:3) and the pH was adjusted to 8 by adding 
1 M NaOH. After stirring at 80 °C for 35 min, compound 26 (2.51 g, 4.7 mmol) was added, 
and the reaction mixture was refluxed for 17 h. After cooling to room temperature the 
solvent was evaporated and the residue was dissolved in ethyl acetate. The solution 
subsequently was washed with saturated NaHCO3 (3x) and brine (3x) followed by drying 
over MgSO4. After removal of the solvent in vacuo the crude product was purified by flash 
column chromatography on flash silica gel (ethyl acetate / MeOH 2:1, Rf = 0.1) obtaining 
27 (1.1 g, 1.15 mmol, 24 %) as a colourless oil. 1H-NMR (400 MHz; acetone-d6):  (ppm) 
= 0.86 (t, 3J = 6.9 Hz, 3 H, C37H3), 1.14-1.28 (m, 30 H, C
22H2 – C
36H2), 1.29 (s, 11 H, 
HSQC: C1H3, C
21H2), 2.87 (dd, 
3J = 13.5 Hz, 2J = 6.5 Hz, 1 H, HSQC, COSY: C6H2), 2.94 
(dd, 3J = 13.5 Hz, 2J = 7.4 Hz, 1 H, HSQC, COSY: C6H2), 3.02 (dd, 
3J = 12.9 Hz, 
2J = 6.6 Hz, 2 H, HSQC: C20H2), 3.74 (d, 
2J = 13.7 Hz, 2 H, HMBC, COSY: C10H2), 3.80 (d, 
2J = 13.7 Hz, 2 H, HMBC, COSY: C10H2), 3.85 (s, 8 H, COSY: C
12H2), 3.34 (dd, 
3J = 14.4 Hz, 2J = 7.1Hz, 1 H, COSY: C20H2), 5.98 (d, 
3J = 8.2 Hz, 1 H, HSQC, COSY: 
N4H), 7.10 (s, 2 H, HMBC, COSY: C8H), 7.20 (ddd, 3J = 7.4 Hz, 4.9 Hz, 1.1 Hz, 4 H, 
HMBC: C16H), 7.29 (bs, 1 H, HSQC, COSY: N19H), 7.55 (d, 3J = 7.8 Hz, 4 H, HMBC: 
C14H), 7.69 (dt, 3J = 7.7 Hz, 2J = 1.9 Hz, 4 H, HMBC: C15H), 8.52 (m, 4 H, HMBC: C17H), 
10.96 (bs, 1 H, HSQC: OH). – 13C-NMR (100 MHz; acetone-d6):  (ppm) = 14.3 (+, 1 C, 
C37H3), 23.3 (–, 1 C, alkyl-CH2), 27.5 (–, 1 C, alkyl-CH2), 28.5 (+, 3 C, C
1H3), 29.9 (–, 1 C, 
alkyl-CH2), 30.22 (–, 1 C, alkyl-CH2), 30.27 (–, 1 C, alkyl-CH2), 30.4 (–, 9 C, alkyl-CH2, 
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solvent peak), 32.6 (–, 1 C, alkyl-CH2), 38.8 (–, 1 C, COSY: C
6H2), 39.7 (–, 1 C, HSQC: 
C20H2), 55.3 (–, 2 C, HMBC, COSY: C
10H2), 60.1 (–, 4 C, HMBC, COSY: C
12H2), 56.9 (+, 
1 C, HMBC: C5H3), 79.0 (Cq, 1 C, HMBC, HSQC, C
2), 122.8 (+, 4 C, HMBC: C16H), 123.8 
(+, 4 C, HMBC: C14H), 124.6 (Cq, 2 C, HMBC: C
9), 127.7 (Cq, 1 C, HMBC: C
7), 131.3 (+, 
2 C, HMBC, COSY: C8H), 137.3 (+, 4 C, HMBC, COSY: C15H), 149.7 (+, 4 C, HMBC, 
COSY: C17H), 155.8 (Cq, 1 C, HMBC: C
11), 155.8 (Cq, 1 C, HMBC: C
11), 159.9 (Cq, 1 C, 
HMBC: C3), 160.2 (Cq, 4 C, HMBC: C
13), 171.9 (Cq, 1 C, HMBC: C
18). – IR (ATR) [cm-1]: 
~
 
[cm] = 3383, 2922, 2852, 1706, 1656, 1590, 1569, 1433, 1364, 1288, 1245, 1167, 1048, 
995, 791. – MS (ESI(+), DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 478.5 (100) 
[M + 2 H+]2+, 955.8 (85) [MH+]. – Elemental analysis calcd. (%) for C58H82N8O4: C 72.92, 
H 8.65, N 11.73; found C 72.38, H 8.34, N 11.63 – MF: C58H82N8O4 – FW: 955.35 g/mol. 
 
2-Amino-3-{3,5-bis-[(bis-pyridin-2-ylmethyl-amino)-methyl]-4-hydroxy-phenyl}-N-octadecyl-
propionamide (28) 
Boc protected 27 (700 mg, 0.73 mmol) was dissolved in DCM under ice cooling and mixed 
with HCl/ether (3.7 mL; 1 mL / 0.2 mmol Boc group). The reaction was allowed to warm to 
room temp. and was stirred for additional 16 hours. After completion the reaction mixture 
was evaporated to dryness, the residue was suspended in saturated NaHCO3 and 
extracted with ethyl acetate (4x). Subsequently the organic phase was dried over MgSO4 
and the solvent was removed in vacuo yielding 28·(497 mg, 0.58 mmol, 79 %) as a pale 
yellow oil. 1H-NMR (300 MHz; DMSO-d6):  (ppm) = 0.82 (t, 3J = 6.9 Hz, 3 H, CH3), 1.04 
(bs, 4 H, alkyl-CH2), 1.19 (s, 28 H, alkyl-CH2), 2.57 (dd, 
3J = 13.5 Hz, 2J = 7.1 Hz, 1 H, Tyr-
CH2), 2.73 (dd, 
3J = 13.5 Hz, 2J = 7.1 Hz, 1 H, Tyr-CH2), 2.91 (m, 2 H, CH2), 3.29 (t, 
3J = 6.4 Hz, 1 H, C H), 3.65 (s, 4 H, Ar-CH2-pyr), 3.74 (s, 8 H, N-CH2-pyr), 6.98 (s, 2 H, 
Ar-CH), 7.21 (m, 4 H, Pyr-CH), 7.46 (d, 3J = 8.0 Hz, 4 H, Pyr-CH), 7.70 (dt, 3J = 7.6 Hz, 
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1.7 Hz, 4 H, pyr-CH), 8.47 (dd, 3J = 4.4 Hz, 0.3 Hz, 4 H, pyr-CH). – 13C-NMR (75 MHz; 
DMSO-d6):  (ppm) = 13.8 (+, 1 C, CH3), 22.0 (–, 1 C, alkyl-CH2), 26.1 (–, 1 C, alkyl-CH2), 
28.52 (–, 1 C, alkyl-CH2), 28.57 (–, 1 C, alkyl-CH2), 28.78, 28.81, 28.89 (–, 11 C, alkyl-
CH2), 31.4 (–, 1 C, alkyl-CH2), 38.0 (–, 1 C, CH2), 40.2 (–, 1 C, CH2), 53.9 (–, 2 C, CH2), 
55.9 (+, 1 C, CH), 58.8 (–, 4 C, CH2), 122.1 (+, 4 C, CH), 122.5 (+, 4 C, CH), 123.1 (Cq, 
1 C), 127.4 (Cq, 1 C), 129.8 (+, 2 C, CH), 136.5 (+, 4 C, CH), 148.5 (+, 4 C, CH), 153.7 
(Cq, 1 C), 158.5 (Cq, 4 C), 173.5 (Cq, 1 C). – IR (ATR) [cm
-1]: 
~
 [cm] = 2921, 2852, 1658, 
1590, 1522, 1474, 1433, 1372, 1233, 1149, 1048, 996, 754. – MS (ESI(+), 
DCM/MeCN/TFA): m/z (%) = 428.4 (100) [M + 2 H+]2+, 299.6 (16) [M + 3 H+ + MeCN]3+, 
855.8 (14) [MH+], 286 (12) [M + 3 H+]. – HRMS Calcd for C53H75N8O2 855.6013; Found: 
855.6000. – MF: C53H74N8O2 – FW: 855.23 g/mol. 
 
Amphiphilic binuclear Zn(II)-Dpa complex (Zn22) 
To a solution of compound 28 (36.5 mg, 43 µmol) in MeOH (2 mL) was added dropwise a 
methanolic solution of ZnCl2 (100 mM, 858 µL, 86 µmol). After stirring the reaction mixture 
for 2 h at room temperature, the methanol was removed in vacuo. The residue was 
dissolved in water and was lyophilized yielding complex 12 as a colourless solid in 
quantitative yield. MP: 147 °C. – IR (ATR) [cm-1]: 
~
= 2924, 2852, 1676, 1608, 1573, 
1477, 1440, 1303, 1270, 1156, 1100, 1053, 1023, 763. – UV (MeOH): max (log  = 261 
(4.076), 296 (3.436). – MS (ESI(+), H2O/MeOH + 10 mmol/L NH4Ac): m/z (%) = 1099.7 
(100) [M3+ + 2 CH3COO
-]+, 520.4 (69) [M3+ + CH3COO
-]2+. – MF: C53H74N8O2Zn2Cl4 – 
FW: 1127.79 g/mol. 
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Isomeric mixture of amphiphilic, fluorescein labeled Dpa ligand (29) 
An isomeric mixture of 5/6-carboxyfluorescein (246 mg, 0.65 mmol), DIPEA (323 µL, 
1.87 mmol), TBTU (315 mg, 0.98 mmol), and HOBt (133 mg, 0.98 mmol) were dissolved 
under nitrogen atmosphere in dry DMF (4 mL) under ice cooling and stirred for 1 h. 
Subsequently 28 (400 mg, 0.47 mmol) in 4 mL DMF was added slowly. The reaction was 
allowed to warm to room temperature and was stirred 22 h at 40 °C. The reaction 
progress was monitored by TLC (CHCl3 / MeOH 9:1). After completion of the reaction the 
solvent was removed and the crude product was purified by preparative HPLC yielding the 
isomers 29 as an orange-yellow solid. MP: 97 – 99 °C. – UV (MeOH): max (log ) = 224 
(4.629), 260 (4.158), 454 (3.500), 481 (3.481). – IR (ATR) [cm-1]: 
~
 [cm] = 2924, 2853, 
1757, 1670, 1609, 1438, 1377, 1246, 1178, 1126, 955, 837, 798, 755, 719. – MS (ESI(+), 
DCM/MeCN/TFA): m/z (%) = 607.6 (100) [M + 2 H+]2+, 405.3 (65) [M + 3 H+]2+, 1213.9 (11) 
[MH+]. – LC-MS (+ p ESI Q1MS ; RT 40 min): m/z (%) = 607.6 (100) [M + 2 H+]2+, 1213.9 
(65) [MH+]+, 405.3 (38) [M + 3 H+]2+. – MF: C74H84N8O8 – FW: 1213.53 g/mol. 
Purification by preparative HPLC: 
Column: LabID75 Phenomenex Luna 250 x 21.2 mm 10 um / Ser.Nr. 453159-3 
Flow:     21 mL / min 
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Concentration   10 mg / mL 
Injection volume:   500 µL 
Detection wavelength:  220 nm 
Gradient:   0 min –  5 % MeCN / H2O (+ 0.0059 % TFA) 
 43 min – 72 % MeCN / H2O (+ 0.0059 % TFA) 
 45 min – 98 % MeCN / H2O (+ 0.0059 % TFA) 
 55 min – 98 % MeCN / H2O (+ 0.0059 % TFA) 
Retention time: ca. 42 min 
 
Fluorescent binuclear Zn(II)-Dpa complex (Zn21) 
To a solution of compound 29 (10.5 mg, 8.7 µmol) in MeOH (2 mL) was added dropwise a 
methanolic solution of MnCl2 (100 mM, 174 µL, 17.4 µmol). After stirring the reaction 
mixture for 2.5 h at room temperature, the methanol was removed in vacuo. The residue 
was dissolved in water and was lyophilized yielding complex 14 as an orange solid in 
quantitative yield (13 mg, 8.7 µmol). MS (ESI(+), H2O/MeOH + 10 mmol/L NH4Ac): 
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m/z (%) = 701.7 (100) [M3+ + CH3COO
-]+, 1398.0 (8) [M3+ - H+ + CH3COO
-]+, 1458.0 (7) 
[M3+ + 2 CH3COO
-]+. – MF: C74H84N8O8Zn2Cl4 – FW: 1486.10g/mol. 
 
Synthesis of amphiphilic Cu(II)-NTA complex Cu3 
Receptor Cu3 was prepared by connecting a carboxytetramethylrhodamine label, an 
ornithine based NTA binding site and a hydrophobic anchor via a central cyanuric chloride 
linker and complexation of the amphiphilic ligand with Cu(II). 
 
Scheme S2. Synthesis of an amphiphilic, fluorescent copper complex: (a) Cbz chloride, DCM, 0°C, 
3 h; (b) tert butyl acetate, HClO4, RT, 72 h; (c) bromo tert butyl acetate, DMF, 55°C, 20 h; (d) 
Pd/C.H2, EtOH, RT, 72 h. 
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Scheme S3. Synthesis of an amphiphilic, fluorescent copper complex: (e) octadecylamine, K2CO3, 
acetone, RT, 20 h; (f) Cbz-diamine 31, K2CO3, acetone, 50°C, 48 h; (g) NTA-precursor 35, 
collidine, dioxane, 140°C (MW), 1.5 h; (h) Pd/C, H2, EtOH, RT, 48 h; 
(i) carboxytetramethylrhodamine, TBTU, HOBt, DIPEA, DMF, 0°C, 1 h / 40°C, 24 h; (j) TFA, RT, 
24 h; (k) Cu2(OH)2CO3, MeOH, 60°C, 4 h. 
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Ethylenediamine 30 is Cbz-protected to give mono-amine 31. Cbz-protected L-ornithine 
32 is converted into the butyl acetate ester 33. The amine group of 33 reacts in a 
nucleophilic substitution with bromo-tert-butyl-acetate to give 34 and yields after 
deprotection the free amine 35. To introduce the hydrophobic anchor octadodecanylamine 
13 is tethered by nucleophilic substitution to cyanuric chloride 36 yielding compound 37. 
Subsequently Cbz-protected ethylenediamine 31 is attached to 37 yielding 38 to connect 
carboxytetramethylrhodamine as fluorescent label. Next, the NTA-precursor 35 is coupled 
to the unprotected functional group of the linker 38 via nucleophilic substitution yielding 
39. Hydrogenolytic Cbz-deprotection gives compound 40, which is tethered to an in situ 
formed active ester of carboxytetramethylrhodamine. Treatment of 41 with TFA leads to 
the free acid 42. In a last step copper is chelated by the acid groups of the NTA-complex 
42 yielding the target receptor Cu3. 
 
Synthesis of benzyl (2-aminoethyl)carbamate (31) 
Ethylenediamine 30 (12.1 mL, 180 mmol) was dissolved in DCM (240 mL) and a solution 
of benzyl chloroformate (2.5 mL, 18 mmol) in DCM (60 mL) was added dropwise over 
1.5 h at 0 °C. The reaction mixture was stirred at this temperature for further 1.5 h and at 
room temperature overnight. The formed precipitate was filtered off, the filtrate was 
washed three times with brine (150 mL) and the organic phase was dried over MgSO4. 
Evaporation of the solvent leads to a pale-yellow, crystalline raw product which was 
purified via column chromatography (silica gel, CHCl3/MeOH/Et3N 70:29:1; Rf = 0.09). The 
product 31 (2.07 g, 10.7 mmol, 59 %) was obtained as pale-yellow oil which crystallizes at 
0 °C. 1H-NMR (400 MHz, CDCl3),  [ppm]: 1.70 (2 H, bs, NH2-CH2), 2.73 (2 H, pt, H2N-
CH2-CH2), 3.17 (2 H, dd, CH2-CH2-NH), 5.05 (2 H, s, O-CH2-C), 5.65 (1 H, bs, CH2-NH-C), 
7.29 (5 H, m, CHarom). – 
13C-NMR (100 MHz, CDCl3),  [ppm]: 156.84 (NH-CO2), 136.64 
(CH2-C-C5H5), 128.51, 128.48, 128.02v (C-C5H5), 66.60 (O-CH2-C), 43.71 (CH2-CH2-NH), 
41.62 (H2N-CH2-CH2). – MS (ESI(+), H2O + 0.1% FA/MeCN + 0.1% FA): m/z (%) = 195.1 
(100) [MH+]. 
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Synthesis of tertbutyl protected 2-amino-5-(((benzyloxy)carbonyl)amino) pentanoic acid 
(33) 
Benzyloxycarbonyl ornithine 32 (10.00 g, 37.55 mmol) was dissolved in tert butyl acetate 
(471 mL, 3.47 mol), perchloric acid (70 %, 5.64 mL, 67.59 mmol) was added and the 
solution was stirred at RT for 72 h. The reaction mixture was cooled to 0°C and four times 
extracted with 0.5 M hydrochloric acid (300 mL). 2 M sodium hydroxide solution was 
added to the aqueous phase and the target molecule was extracted from the basic 
solution with diethyl ether (three times, 200 mL), dried over Na2SO4 and the solvent was 
removed in vacuo. 33 was obtained as yellow oil (8.61 g, 26.71 mmol, 71 %). – 1H-NMR 
(400 MHz, CDCl3):  [ppm] = 1.43 (s, 9H, CH3), 1.55 – 1.70 (m, 4H, 2x CH2), 3.18 (m, 2H, 
CH2-NH), 3.30 (m, 1H, CH), 5.05 (s, 2H, CH2-Cbz), 5.25 (s, 1H, NH), 7.25 –
 7.36 (m, 5H, CHaromat.). – 
13C-NMR (100 MHz, CDCl3):  [ppm] = 26.0 (CH3), 28.2 (CH2), 
40.9 (CH2), 54.4 (CH), 66.6 (CH2), 81.3 (CHquart.), 128.6 (CHarom.), 137.0 (Cquart,arom.), 
156,5 (Ccarbonyl), 175,0 (Ccarbonyl). – MS (ESI(+), H2O + 0.1% FA/MeCN + 0.1% FA): 
m/z (%) = 323.0 (100) [MH+], 645.4 (36) [2MH+]. 
 
Synthesis of di-tert-butyl 2,2'-((5-(((benzyloxy)carbonyl)amino)-1-(tert-butoxy)-1-
oxopentan-2-yl)azanediyl)diacetate (34) 
Two-fold protected ornithine 33 (8.61 g, 26.71 mmol), tert butyl bromoacetate (15.50 mL, 
106.82 mmol) and DIPEA (22.71 mL, 133.53 mmol) were dissolved in dry DMF (100 mL) 
under nitrogen atmosphere and the mixture was stirred at 55 °C for 20 h. Subsequently 
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the solvent was removed under vacuo yielding a dark brown solid which was suspended 
in ethyl acetate (60 mL) and filtered off. The residue was washed three times with 
hexane/ethyl acetate (3:1, 120 mL). After evaporation a brown oil (17.54 g) was obtained. 
The crude product was purified via column chromatography (flash silical gel, hexanes/EA 
3:1; Rf = 0.27) to give 34 as pale yellow solid (12.74 g, 23.mmol, 86 %). – 
1H-NMR 
(400 MHz, CDCl3):  [ppm] = 1.38 (s, 27H, CH3), 1.55 – 1.70 (m, 4H, 2x CH2), 3.16 –
 3.25 (m, 3H, CH and CH2-NH), 3.30 – 3.44 (m, 4H, 2x CH2-Ntert.), 5.00 (s, 2H, CH2-Cbz), 
5.22 (s, 1H, NH), 7.21 – 7.27 (m, 5H, CHaromat.). – 
13C-NMR (100 MHz, CDCl3): 
 [ppm] = 26.0 (CH3), 28.2 (CH2), 40.6 (CH2), 54.0 (CH), 65.1 (CH2), 66.4 (CH2), 81.2 
(CHquart.), 128.0 (CHarom.), 136.8 (Cquart,arom.), 156.5 (CHcarbonyl), 175.1 (CHcarbonyl). – MS 
(ESI(+), H2O + 0.1% FA/MeCN + 0.1% FA): m/z (%) = 551.2 (100) [MH
+]. 
 
Synthesis of di-tert-butyl 2,2'-((5-amino-1-(tert-butoxy)-1-oxopentan-2-
yl)azanediyl)diacetate (35) 
Cbz-protected NTA-precursor 34 (484 mg, 0.51 mmol) was dissolved in ethanol (15 mL) 
and Pd/C (500 mg) was added. The reaction mixture was stirred at RT and under 
hydrogen atmosphere (30 bar) for 72 h. Subsequently Pd/C was filtered off via celite and 
the solvent was evaporated yielding the yellow oil 35 (372 mg, 0.45 mmol, 89%). 1H-NMR 
(300 MHz, CDCl3)  [ppm] = 5.00 (bs, 1 H, NH), 3.41 (s, 2 H, CH2-N), 3.38 (s, 2 H, CH2-N), 
3.31 (m, 1 H, CH-N), 2.85 (m, 2H, CH2-NH2), 1.52- 1.87 (m, 4 H, 2x CH2alkyl), 1.41 - 1.38 
(m, 27 H, CH3). – 
13C-NMR (100 MHz, CDCl3)  [ppm] = 171.82 (COO), 170.68 (COO), 
81.40 (COquart.), 81.03 (COquart.), 65.21 (CH-N), 57.79 (CH2-N), 40.36 (CH2-NH2), 28.13 
(CH2alkyl), 28.04 (CH3), 27.04 (CH2-CH), 18.30 (CH3). – MS (ESI(+), H2O + 0.1% FA/MeCN 
+ 0.1% FA): m/z (%) = 417.3 (100) [MH+]. 
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Synthesis of 4,6-dichloro-N-propyl-1,3,5 triazin-2-amine (37) 
Octadecylamine (1.02 g, 5.50 mmol) was dissolved in acetone (40 mL) and a solution of 
2,4,6-trichloro-1,3,5-triazine 36 (1.47 g, 5.44 mmol) in acetone (25 mL) and water (5 mL) 
was added at 0 °C, followed by the addition of K2CO3 (2.25 g, 16.28 mmol) in water 
(10 mL). The reaction mixture was stirred at 0 °C for further 30 min and at RT for 20 h. 
After the solvent was removed in vacuo the residue was washed with brine (5 mL) and 
extracted three times with CHCl3 (25 mL). The organic phases were dried over MgSO4 
and the solvent was evaporated to give a white powder (2.20 g). The crude product was 
purified via silica column chromatography (hexanes/EA 10:1; Rf = 0.37) yielding the white 
solid 37 (1.30 g, 3.11 mmol, 57 %). – 1H-NMR (300 MHz, CDCl3)  [ppm] = 3.47 (q, 2H, 
CH2-NH), 1.59 (m, 2H, CH2alkyl), 1.25 -1.32 (m, 30H, 15 x CH2alkyl), 0.88 (t, 3H, CH3). – 
13C-NMR (100 MHz, CDCl3)  [ppm] = 171.01 (Carom.-NH), 165.83 (Carom.-Cl), 41.58 
(CH2alkyl), 31.94 (CH2alkyl), 29.48 (CH2alkyl), 26.64 (CH2alkyl), 22.71 (CH2alkyl), 14.14 (CH3). – 
MS (ESI(+), H2O + 0.1% FA/MeCN + 0.1% FA): m/z (%) = 417.2 (100) [MH
+]. 
 
Synthesis of benzyl (2-((4-chloro-6-(propylamino)-1,3,5-triazin-2-yl) 
amino)ethyl)carbamate (38) 
Amphiphilic triazine 37 (4.50 g, 10.80 mmol) was dissolved in acetone (50 mL) followed by 
the addition of Cbz-protected ethylendiamine 31 (2.10 g, 10.80 mmol) and K2CO3 (7.46 g, 
54.00 mmol). The mixture was stirred at 50 °C for 40 h before the solvent was removed in 
vacuo. The residue was redissolved in CHCl3 (100 mL) and washed three times with a 
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water/brine solution (2:1, 100 mL). The organic phases were dried over MgSO4 and the 
solvent was evaporated. The obtained crude product was recrystallized from EA yielding 
38 as a light brown solid (3.46 g, 6.01 mmol, 56 %). 1H-NMR (300 MHz, CDCl3) 
 [ppm] = 7.29 (m, 5 H, CHarom), 5.08 (s, 2 H, CH2-Cbz.), 3.56 (m, 2 H, CH2alkyl), 3.27- 3.45 
(m, 4 H, CH2-CH2), 1.53 (t, 2 H, CH2alkyl), 1.25 (bs, 30 H, 15 x CH2alkyl), 0.88 (t, 3 H, CH3). – 
13C-NMR (100 MHz, CDCl3)  [ppm] = 136.53 (Carom), 128.07- 128.54 (CHarom.), 66.72 
(CH2-CH2), 41.05 (CH2alkyl), 31.94 (CH2alkyl), 29.38 - 29.72 (CH2alkyl), 22.71 (CH2alkyl), 14.14 
(CH3). – MS (ESI(+), H2O + 0.1% FA/MeCN + 0.1% FA): m/z (%) = 574.4 (100) [MH
+]. 
 
Synthesis of di-tert-butyl 2,2'-((5-((4-((2-(((benzyloxy)carbonyl)amino) ethyl)amino)-6-
(octadecylamino)-1,3,5-triazin-2-yl)amino)-1-(tert-butoxy)-1-oxopentan-2-
yl)azanediyl)diacetate (39) 
Amine 35 (1.00 g, 2.47 mmol) was suspended in dioxane (10 mL) followed by the addition 
of the two-fold substituted triazine 38 (1.42 g, 2.47 mmol) and collidine (1.63 µl, 
12.37 mmol). The reaction was carried out in a microwave (150 W, 1.7 bar) at 140 °C for 
1.5 h. After evaporation a brown oil was obtained. The crude product was purified via 
column chromatography (flash silica gel, EA/hexanes/Et3N 75:20:5; Rf = 0.43) to give 
product 39 as a dark yellow oil (0.48 g, 0.51 mmol, 21 %). 1H-NMR (300 MHz, CDCl3) 
 [ppm] = 7.29 - 7.33 (m, 5 H, CHarom), 5.07 (s, 2 H, CH2-Cbz), 3.26 - 3,50 (m, 13 H, CH 
and 6 x CH2alkyl), 1.70 (m, 2 H, CH2alkyl), 1.64 (m, 2 H, CH2alkyl), 1.50 (t, 2 H, CH2alkyl), 1.43 
(bs, 30 H, CH2alkyl), 1.24 (bs, 27 H, CH3), 0.88 (t, 3 H, CH3). – 
13C-NMR (100 MHz, CDCl3) 
 [ppm] =172.22 (COO), 170.66 (COO), 136.73 (CHarom)), 128.45 (CHarom)), 127.96 
(CHarom), 81.11 (COquart), 80.67 (COquart), 66.49 (CHCOO), 65.1, (CH2O), 53.82 (CH2-N), 
40.68 (CH2-NH), 40.39 (CH2-NH), 31.92 - 26.22 (CH2alkyl), 26.97 (CH3), 22.69 (CH2-CH3), 
14.12 (CH3). – MS (ESI(+), H2O + 0.1% FA/MeCN + 0.1% FA): m/z (%) = 478.4 (100) 
[M + 2 H+]2+, 955.8 (64) [MH+]. 
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Synthesis of di-tert-butyl 2,2’-(5-((4-((2-aminoethyl)amino)-6-(octodecylamino)-1,3,5-
triazin-2-yl)amino)1-(tert-butoxy)-1-oxopentan-2-yl)azanediyl)diacetate (40) 
Cbz-protected spacer moiety 39 (190 mg, 0.20 mmol) was dissolved in ethanol (15 mL) 
and Pd/C (500 mg) was added. The reaction mixture was stirred at RT and under 
hydrogen atmosphere (30 bar) for 48 h. Subsequently Pd/C was filtered off via celite and 
the solvent was evaporated yielding 40 as light-yellow oil (156 mg, 0.19 mmol, 95%). 
1H-NMR (300 MHz, CDCl3)  [ppm] = 3.26 – 3.58 (m, 13 H, CH and 6 x CH2alkyl), 1.71 (m, 
2 H, CH2alkyl), 1.64 (m, 2 H, CH2alkyl), 1.55 (t, 2 H, CH2alkyl), 1.42 (bs, 30 H, CH2alkyl), 1.24 
(bs, 27 H, CH3), 0.88 (t, 3 H, CH3). – 
13C-NMR (100 MHz, CDCl3)  [ppm] =172.22 (COO), 
170.66 (COO), 136.73 (CHarom)), 128.45 (CHarom)), 127.96 (CHarom), 81.11 (COquart), 80.67 
(COquart), 66.49 (CHCOO), 65.1. (CH2O), 53.82 (CH2-N), 40.68 (CH2-NH), 40.39 (CH2-NH), 
31.93 - 26.22 (CH2alkyl), 26.97 (CH3), 22.69 (CH2-CH3), 14.13 (CH3). – MS (ESI(+), H2O + 
0.1% FA/MeCN + 0.1% FA): m/z (%) = 411.2 (70) [M + 2 H+]2+, 431.8 (100) [M + 2 H+ + 
MeCN]2+, 821.7 (30) [MH+]. 
 
 
1 
Dynamic Interface Imprinting: High Affinity Peptide Binding Sites Assembled by Analyte-induced 
Recruiting of Membrane Receptors 
 
26  
 
 
Synthesis of 4-((2-((4-((4-(bis(2-(tert-butoxy)-2-oxoethyl)amino)-5-(tert-butoxy)-5-
oxopentyl)amino)-6-(octadecylamino)-1,3,5-triazin-2-yl)amino) ethyl)carbamoyl)-2-(6-
(dimethylamino)-3-(dimethyliminio)-3H-xanthen-9-yl)benzoate (41) 
Carboxytetramethylrhodamine (180 mg, 0.42 mmol), TBTU (148 mg, 0.46 mmol), HOBt 
(62 mg, 0.46 mmol) and DIPEA (284 µL, 1.67 mmol) were dissolved in dry DMF (4.5 mL) 
under nitrogen atmosphere at 0°C and the reaction mixture was stirred at RT. After 1 h a 
solution of the receptor-precursor 40 (343 mg, 0.42 mmol) in dry DMF (3 mL) was added 
dropwise over 35 min. The reaction mixture was warmed to 45 °C and stirred for another 
40 h. Subsequently the solvent was removed and the pink residue was purified via column 
chromatography (flash silica gel, EA/MeOH/Et3N 75:20:5) to give 41 as magenta oil. 
(76 mg, 0.06 mmol, 15 %). 1H-NMR (300 MHz, CDCl3)  [ppm] = 0.80 (t, 3 H, CH3), 1.11 
(m, 2 H, CH2 alkyl), 1.17 (m, 28 H, CH2 alkyl ), 1.27 (m, 2 H, CH2 alkyl), 1.35 (s, 27 H, CH3 Boc), 
1.45 – 1.73 (m, 4 H, CH2 alkyl), 3,00 (m, 12 H, CH3-N), 3.16-3.55 (m,13 H, CH2 and CH), 
7.22 (s, 1H, arom.), 7.34 – 7.49 (m, 4 H, arom), 7.64 – 7.67 (m, 4H, arom.). – 13C-NMR 
(100 MHz, CDCl3)  [ppm] = 8.7, 14.1, 22.7, 28.0, 28.3, 29.7, 31.9, 45.7, 53.4, 110.7, 
110.9, 118.5, 124.0, 125.1, 127.8. – MS (ESI(+), H2O + 0.1% FA/MeCN + 0.1% FA): 
m/z (%) = 1234.0 (100) [MH+]. 
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Synthesis of 4-((2-((4-((4-(bis(carboxymethyl)ammonio)-4-carboxybutyl) amino)-6-
(octadecylamino)-1,3,5-triazin-2-yl)amino)ethyl)carbamoyl)-2-(6-(dimethylamino)-3-
(dimethyliminio)-3H-xanthen-9-yl)benzoate (42) 
41 (92 mg, 0.08 mmol) was dissolved in TFA (1.6 mL, 20.77 mmol) and stirred at RT for 
30 h. TFA was evaporated in vacuo, the residue was suspended in water (3 mL) and 
lyophilized giving product 42 (83 mg, 0.08 mmol, 98 %) as a magenta solid. 1H-NMR 
(600 MHz, CDCl3)  [ppm] = 0.86 (t, 3 H, CH3), 1.15 – 1.28 (m, 28 H, CH2 alkyl), 1.36-1.38 
(m, 4 H, CH2 alkyl ), 1.39 – 1.42 (m, 12 H, CH3), 3.09 – 3.15 (m, 5 H, CH-(CH2)2), 3.16 – 
3.20 (m, 8 H, CH2-NH), 3.69 – 3.71 (m, 4 H, CH2-COOH), 6.61 (bs,1 H, NH), 6.74 (bs,1 H, 
NH), 6.98 (bs,1 H, NH), 7.39 (t, 1H, CHarom.), 7.41 – 7.53 (m, 4 H, CHarom.), 7.56 (d, 1H, 
CHarom.), 7.75 – 7.83 (m, 2H, CHarom.), 8.02 (d, 1H, CHarom.), 8.61 (bs,1 H, NH), 9.12 
(bs,1 H, NH). – 13C-NMR (150 MHz, CDCl3)  [ppm] = 14.1 (+, 1 C, CH3), 17.3 (+, 2 C, 
CH3), 18.5 (+, 2 C, CH3), 22.6 (-, 1 C, CH2 alkyl), 28.8 – 29.7 (-, 16 C, CH2 alkyl), 31.9 (-,1 C, 
CH2 alkyl), 40.6 (+, 1 C, CH), 41.0 (-, 1 C, CH-(CH2)2), 42.5 (-, 1 C, CH-(CH2)2), 46.3 (-, 4C, 
CH2-NH), 54.4 (-, 2 C, CH2-COOH), 109.8 (+, 1 C, CHarom.), 112.6 (+, 1 C, CHarom.), 114.1 
(+, 1 C, CHarom.), 114.7 (-, 1 C, Cq), 114.8 (-, 1 C, Cq), 116.7 (-, 1 C, Cq), 118.6 (-, 1 C, Cq), 
119.7 (+, 1 C, CHarom.), 124.8 (+, 1 C, CHarom.), 127.0 (+, 1 C, CHarom.), 128.1 (+, 1 C, 
CHarom.), 128.6 (+, 1 C, CHarom.), 128.9 (+, 1 C, CHarom.), 130.4 (-, 1 C, Cq), 130.9 (-, 1 C, 
Cq), 136.6 (-, 1 C, Cq), 142.5 (-, 1 C, Cq), 157.0 (-, 1 C, Cq), 157.3 (-, 1 C, Cq), 160.6 (-, 
1 C, Cq), 160.9 (-, 1 C, Cq), 161.1 (-, 1 C, Cq), 161.4 (-, 1 C, Cq). – MS (ESI(+), 
DCM/MeOH + 0.1% FA): m/z (%) = 533.5 (100) [M + 2 H+]2+, 1065.7 (26) [MH+]. 
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Synthesis of the amphiphilic, labeled Cu(II)-NTA-complex (Cu3) 
Deprotected 42 (83.0 mg, 0.08 mmol) was dissolved in MeOH (1.5 mL) and a suspension 
of Cu(OH)2CO3 and a very small amount of MeOH was added. The reaction was 
completed by stirring the mixture at RT for 20 h and at 60°C for 3 h. Subsequently the 
warm solution was filtered immediately and the solvent was evaporated. The residue was 
suspended in water (2 mL) and lyophilized yielding Cu3 (89.0 mg, 0.08 mmol, 99 %) as a 
dark magenta solid. MS (ESI(-), H2O/MeOH + 10 mmol/L NH4Ac): m/z (%) = 1124.4 (100) 
[M - H - 2 H2O]
-. 
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Scheme S4. Structures and symbols of (non-)amphiphilic receptors and ligands (counterions 
omitted). 
 
Receptor-ligand binding in homogeneous (Zn26, Zn46) and vesicular (Zn25) solution 
 
Figure S1. (a) Schematic recognition of P1 in homogeneous aqueous solution by previously 
developed receptors
26
 Zn26 and Zn46; (b) Schematic recognition of P1 by membrane-embedded 
receptor Zn25 in DSPC and DOPC vesicles. 
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Vesicles 
Preparation 
In small glass reaction vessels 1 - 5 µmol of DOPC or DSPC were dissolved in chloroform 
and optionally 0.1-10 mol% of dissolved metal complexes were added and mixed. The 
solvent was completely removed under reduced pressure at 25 °C (DOPC) or 75˚C 
(DSPC) and an appropriate amount of buffer (HEPES 10 mM, pH 7.4) was added to 
obtain lipid concentrations of 1 - 2 mM. Vigorous shaking at 25 °C (DOPC) or 75 °C 
(DSPC) for 5 - 10 minutes yielded a turbid multi-lamellar vesicle suspension. Small uni-
lamellar dispersions were obtained by extrusion through 100 nm-pore size polycarbonate 
membranes with a LiposoFast liposome extruder from Avestin.37 
Metal complex concentration 
For all vesicles the receptor concentration refers to the outer surface exposed binding 
sites, as only these should be reactive, with the assumption that embedded compounds 
distribute equally in both layers of the vesicle membrane and the bilayer thickness for the 
prepared vesicles amounts to 5 nm.11, 38-40 
Dynamic light scattering (DLS) 
Vesicle size distributions were determined using Dynamic light scattering (DLS). The 
standard size distribution of species obtained after extrusion is the following: 
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Figure S2. Typical size distribution of 100 nm-sized vesicles. 
In order to remove low molecular weight solutes vesicles can be purified by size exclusion 
chromatography via small spin columns.41 For this Sephadex LH-20 SEC medium was 
swollen in buffer solution prior to use. 5 mL bed volume per mL vesicle suspension was 
transferred into a small plastic syringe with filter support and removed plunger and the 
solvent removed by centrifugation (Eppendorf bench top centrifuge, 15 sec @ 4400 rpm). 
Vesicle solutions were added onto the column and recovered by subsequent 
centrifugation. 
Cu- and Zn-quantification via atomic emission spectroscopy (ICP-AES) 
In order to verify the receptor concentration of prepared vesicles their total metal content 
was measured via ICP-AES on a Spectro Flame-EOP spectrometer. Standard curves 
were recorded in Millipore water to quantify Cu and Zn in stock solutions of Cu3 and Zn21. 
Metal contents were again determined after receptor-embedding in vesicle membranes 
and purification of vesicular solutions via SEC. 
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Figure S3. Absolute (left; in mM) and relative (right) concentrations of Cu and Zn in stock solutions 
of Cu3 and Zn21 and corresponding vesicle preparations before and after purification via SEC. 
 
Supporting experimental data for Zn25-vesicles vs. P1 
 
Figure S4. Raw emission spectra of P1 in the presence of increasing amounts of receptor-
vesicles. 
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Figure S5. Emission response of Zn25 doped (1 mol% each) DOPC and DSPC vesicle 
membranes. 
 
 
Figure S6. Non-linear curve fitting of DOPC-vesicles doped with 1 mol% Zn25. 
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Figure S7. Non-linear curve fitting of DSPC-vesicles doped with 1 mol% Zn25. 
 
Figure S8. Non-linear curve fitting of DSPC-vesicles doped with 10 mol% Zn25. 
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Figure S9. Job’s Plot (limiting reagent method) of P1 vs. DSPC-vesicles doped with 1 mol% Zn25. 
 
Figure S10. Job’s Plot (limiting reagent method) of P1 vs. DSPC-vesicles doped with 1 mol% Zn25. 
 
Figure S11. Size distributions of vesicles doped with 1 mol% Zn25 in the presence of increasing 
amounts of P1 (0.5 – 200 eq.) showing no apparent crosslinking of membranes. 
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Supporting experimental for Zn22/Cu4-vesicles vs. P1 
 
Figure S12. Non-linear curve fit for Zn22 (1 mol%) in DOPC-vesicles. 
 
Figure S13. Non-linear curve fit for Cu4 (1 mol%) in DOPC-vesicles. 
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Figure S14. Non-linear curve fit for Zn22 + Cu4 (1 mol% each) in DOPC-vesicles. 
 
Figure S15. Non-linear curve fit for Zn22 (1 mol% each) in DSPC-vesicles. 
 
Figure S16. Non-linear curve fit for Cu4 (1 mol% each) in DSPC-vesicles. 
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Figure S17. Non-linear curve fit for Zn22 + Cu4 (1 mol% each) in DSPC-vesicles. 
 
Figure S18. Job’s Plot (limiting reagent method) of P1 vs. DSPC-vesicles doped with Zn22 + Cu4 
(1 mol% each). 
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Figure S19. Job’s Plot (limiting reagent method) of P1 vs. DOPC-vesicles doped with Zn22 + Cu4 
(1 mol% each). 
 
Supporting experimental for Zn21/Cu3-vesicles vs. P2 
  
Figure S20. Fluorescence emission spectra of DSPC (left) and DOPC (right) vesicles equipped 
with Cu3 and Zn21 (0.5 mol% each). 
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Figure S21. Raw emission spectra of DOPC vesicles functionalized with either 0.1 mol% of Zn21 
(left) or Cu3 (right) in the presence of increasing amounts of mono- or divalent peptide ligands (P0, 
PH, PP or P2, 0 – 100 eq.). Peptide binding towards these mono-receptor-vesicles does not 
produce a significant emission response. 
  
Figure S22. Emission spectra of DSPC vesicles (left) and DOPC vesicles (right) functionalized with 
0.5 mol% Cu3 and Zn21 each in the presence of increasing amounts of P2. 
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Figure S23. Emission spectra of DOPC vesicles (0.5 mol% Cu3 and Zn21) in the presence of 
equivalent amounts of the control peptides PH, PP and P0 compared to P2. 
 
Figure S24. Observed particle size distribution for mixtures of DOPC/Cu3-vesicles (0.1 mol%) and 
DOPC/Zn21-vesicles (0.1mol%) before (red) and after (green) treatment with P2 showing no 
apparent crosslinking and increase in vesicle size. 
 
Figure S25. Observed particle size distribution for DOPC vesicles functionalized with Cu3 and 
Zn21 (0.1 mol% each) before (red) and after (after) treatment with P2 showing no apparent 
crosslinking and increase in vesicle size. 
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CHAPTER 2 
THERMALLY INDUCED MOLECULAR IMPRINTING OF LUMINESCENT VESICLES 
 
 
Thermal imprinting of the lipid-water interface of phospholipid vesicles is achieved by 
reversible non-covalent assembly of membrane embedded amphiphilic metal complexes. 
The complexes have affinity to phosphate and imidazole groups and are preorganized by 
a phosphorylated hexapeptide template above the phase transition temperature. The 
template induced patterning is transferred into the gel phase of the membrane by cooling 
below the transition temperature. This limits the lateral diffusion and stabilizes the metal 
complex receptor organization, as confirmed by FRET measurements with dye-labeled 
receptors. After template removal an enhanced rebinding affinity of one order of 
magnitude for the target peptide was observed for the imprinted membranes compared to 
identical non-imprinted interfaces. 
 
This Chapter has been published: 
S. Balk and B. König, J. Incl. Phenom. Macrocycl. Chem., 2014, DOI 10.1007/s10847-014-0442-2. 
Author contributions: 
SB synthesized vesicles, performed measurements and wrote the manuscript; BK supervised the 
project and is corresponding author. 
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Introduction 
Template guided assembly and molecular imprinting are established strategies to improve 
ligand binding by creating specific receptors.1-4 A multivalent target analyte binds 
reversible-covalently2 or non-covalently4 to molecules of complementary shape, charge 
and functional groups. Copolymerization of the assembly fixes the individual binding sites 
in the right spatial distance creating a specific receptor site that may provide a selective 
analyte rebinding after template removal. Such imprints have been applied in analyte 
sensing,5-9 catalysis10-12 or enzyme inhibition13-16 and molecular imprinted polymers are 
already commercial products. However, the cross-linked bulk materials posses only a 
limited rebinding capacity, poor binding site accessibility and have long diffusion ways.1 
Surface imprinting can overcome these drawbacks  and artificial binding sites have been 
attached to the surface of carbon nanotubes,17, 18 silica beads,19, 20 polymer 
microspheres,21 magnetic nanoparticles22 or nanogels.23, 24 Another challenge is the use of 
molecular imprints in water for which e.g. hydrophilic surface functionalization25, 26 and 
molecular imprinting of vesicles27 have been developed.  
The common strategy in imprinting is the irreversible covalent fixation of binding moieties 
by radical polymerization and crosslinking. Hence the optimized spatial arrangement of 
functional groups in the non-covalent assembly is altered during the covalent bond 
formation, which implies a loss of binding specificity that cannot be avoided. An alternative 
approach for crosslinking is changing the mobility of membrane embedded binding sites. 
Bayerl et al. demonstrated the molecular imprinting of a silica bead supported liposomal 
bilayer by thermal phase transition:28 Cationic lipids in a phospholipid membrane were 
molded by non-specific attractive interactions using protein templates. Other examples 
have used temperature responsive conformation,29 thermo-reversible swelling of 
hydrogels30-32 or bond reorganization, so called “post imprinting”,33, 34 altering the 
selectivity of an already molecular imprinted polymer. We report here the thermal non-
covalent imprinting of amphiphilic metal complex receptors in the dynamic lipid-water 
interface of phospholipid vesicles.35-37 Analyte binding to the phase segregated 
receptors38, 39 induces their rearrangement and specific positioning in the fluid 
membrane.40, 41 This analyte-induced arrangement is then non-covalently cross-linked by 
cooling the vesicles below their phase transition temperature from liquid-crystalline to gel 
phase suppressing lateral diffusion.42-44 
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Scheme 1. Principle of thermal surface imprinting and analyte induced luminescent response 
(SEC: size exclusion chromatography). 
 
Results and Discussion 
We first monitored by fluorescence resonance energy transfer (FRET) the rearrangement 
of dye-labeled metal-complexes Zn2FAM and CuTMR (Scheme 2) in a fluid membrane 
upon binding to a divalent peptide P1 bearing phosphorylated serine and histidin moiety 
as ligands.40 In order to show that the peptide-induced receptor assembly on the vesicle 
surface is transferred from the liquid-crystalline into gel phase, we prepared DPPC 
vesicles V1 (TM = 41 °C), functionalized with 0.75 mol% of Zn2FAM and CuTMR in 
HEPES buffer (25 mM, pH = 7.4). FAM- and TMR-labels are established FRET pairs with 
a Förster-radius of 5.5 nm. The FRET emission of V1, with typical intensity maxima at 
520 nm and 580 nm, was monitored in the presence and the absence of P1 after donor-
dye excitation at 494 nm.i No receptor rearrangement was detected upon analyte addition 
below the TM at 10 °C, as the mobility of the embedded receptors is limited. A significant 
change of the FRET ratio was detected using the same solutions at 50 °C (Figure 1 gives 
the FRET ratios). In the now fluid membrane the analyte-induced recruiting of the 
labeled receptors leads to a closer proximity and an increase of the FRET intensity. The 
receptor orientation is maintained when going back to the gel phase by fast cooling of V1 
from 50 °C to 10 °C as indicated by an unchanged FRET ratio  (see SI for detailed 
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procedure). The FRET experiments show that template guided orientation of two 
receptors is stronger than the potential phase separation in vesicular DPPC membranes, 
which reorganize from liquid crystalline to gel phase.ii 
 
 
Scheme 2. Structures of functional amphiphiles and model peptide (counter ions omitted for 
clarity). 
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Figure 1. The peptide-induced arrangement of receptors in the bilayer above TM can be transferred 
to the gel phase by cooling. The change of the FRET ratio (FRET ratio) indicates different 
average distances between the receptors in the presence and the absence of P1 after the 
heating/cooling cycle. 
However, the use of FRET labeled receptors does not allow determining analyte binding 
constants, as the absolute fluorescence intensity and the energy transfer between the 
dyes changes in the binding process. Therefore, we co-embedded an amphiphilic reporter 
dye FAM (1 mol%) with Zn2BC receptors (1 mol%) (molecules shown in scheme 2)
35 in 
100 nm DMPC vesicles V2 (TM = 24 °C) in HEPES buffer (25 mM, pH = 7.4) (see SI for 
vesicle preparation). Differential scanning calorimetry (DSC) confirms no alteration of the 
phase transition temperature by the vesicle functionalization (see SI).iii 
The binding of external added P1 to vesicular attached Zn2BC is monitored by a changing 
fluorescence intensity of the coembedded FAM, which is caused by an altered phase 
separation driven assembly of the dye and the receptor after analyte binding.35 The 
changes in the local molecular environment of the dye molecule affect its emission 
properties. This receptor-dye co-embedding technique was recently used to monitor 
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analyte binding in covalently imprinted vesicles.27 The buffered aqueous solution 
containing V2 was warmed to 35 °C before template addition (for a detailed imprinting 
procedure, see SI). Stoichiometric template binding ([Zn2BC] / [P1] 2:1) arranges the 
metal complex receptors in the liquid crystalline phase. Quick cooling of the solution below 
the phase transition temperature of V2 imprints this arrangement into the bilayer by 
reducing the mobility of the embedded receptors. The template P1 was removed by size 
exclusion chromatography (see SI) below TM at 10°C and the rebinding of peptide P1 to 
the thermally imprinted vesicle V2 investigated. The fluorescence intensity change of FAM 
upon addition of P1 was monitored at 520 nm (excitation at 485 nm) for the imprinted 
vesicles and compared to identically treated non-imprinted samples. The apparent binding 
constants were determined by non-linear fitting of the experimental data using the Hill 
equation (Figure 2). 
 
Figure 2. Changes in emission intensity (excitation at 485 nm, detection at 520 nm) of solutions of 
imprinted (blue) and non-imprinted (red) vesicles V2 (DMPC 1 x 10
-5
 mol/L, Zn2BC 1 x 10
-7
 mol/L 
and FAM 1 x 10
-7
 mol/L) upon titration with peptide P1. 
The addition of one equivalent P1 to the imprinted V2 leads to a significant change in 
emission intensity reaching saturation. A binding affinity enhancement of one order of 
magnitude was observed for the rebinding of P1 to imprinted vesicle with a log K = 8.2 
(Figure 2). The positive cooperativity (n = 1.4) for imprinted vesicles and Job’s plot 
analysis indicate a binding of preorganized Zn2BC to P1 with a ratio of 2:1 (see SI). In 
comparison, a binding affinity of log K = 7.0 was determined for non-imprinted vesicles. 
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We assume a reversible monovalent binding of P1 to non-imprinted vesicles resulting in a 
peptide to receptor stoichiometry of 1:1. The Hill equation fit shows a slightly negative 
cooperativity (n = 0.8) (see SI). We expect that the low lateral diffusion in the membrane 
gel phase prevents a divalent binding. 
A rebinding affinity enhancement of P1 to thermally imprinted membranes is detected, 
compared to identical vesicles lacking a preorganizing template during the thermal cycle.iv 
The thermal imprinting of the surface is lost by heating: Imprinted vesicles were heated 
after template removal above their TM, and the rebinding titrations after cooling resulted in 
a value of log K = 7.4 (see SI), which is comparable to the non-imprinted vesicles.  
Previous studies showed an affinity enhancement of three orders of magnitude for 
covalently surface imprinted vesicles by photopolymerization with a value of log K = 7.4 in 
comparison to a log K = 4.6 for non-imprinted vesicles.27 The much lower affinity 
enhancement for non-covalent surface imprinted vesicles may be explained by dynamic 
phase segregation,38, 39 which competes with the imprinted assembling. 
 
Conclusion 
In conclusion, we have demonstrated the alteration of the binding behavior of 
functionalized vesicles to a peptide by preorganizing membrane embedded receptors in 
the fluid phase and transferring this arrangement to the gel phase by lowering the 
temperature.  A hexapeptide, which is able to bind simultaneously to two metal complex 
receptors, was used to assemble the binding sites in the liquid-crystalline phase of DMPC 
and DPPC membranes. This template induced patterning was stabilized by phase 
transition to the gel phase of the liposomal membrane, as shown by FRET 
measurements. Specific rebinding of the target peptide to thermally imprinted vesicular 
receptors provides an enhancement of affinity of one order of magnitude after template 
removal. 
Although the increase in binding affinity by the thermal imprint procedure is too small to be 
useful for a selective analyte detection, the immobilization of the membranes and 
applications e.g. in affinity chromatography28 or other chromatographic separations may 
be envisaged.  
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Experimental Part and Supporting Information 
General methods and material 
Fluorescence measurements were performed in aqueous HEPES buffer (Sigma-Aldrich, 
sodium salt 99%, 25 mM, pH 7.4), using 0.2 cm or 0.4 cm quartz cuvettes (Hellma). 
Emission spectra were recorded on a Horiba “Fluoromax4” fluorescence 
spectrophotometer with temperature control for required temperatures (2 min equilibration 
time).  DLS measurements were performed on a Malvern Zetasizer Nano at 20 °C using 
1 cm disposable polystyrene cuvettes (VWR). DSC measurements were recorded with a 
Perkin Elmer DSC 8000. Starting materials were used without any further purification. 
Phospholipids were purchased from Avanti Polar Lipids Inc. Commercially available 
solvents of UV-grade quality (Merck) and water of millipor quality were used. Sephadex 
G25 “Coarse” from Sigma-Aldrich was used for size exclusion chromatography. 
 
Receptors and Analyte 
Zn2FAM,
40 CuTMR,40 Zn2BC
35 and FAM35 were synthesized by following synthetic 
procedures previously reported by us. Model Peptide P1 was purchased from GL 
Biochem (Shanghai) Ltd. (purity > 95%). 
 
Vesicles 
Preparation 
In small glass reaction vials the required volumes of solutions of DMPC or DPPC (20 mM 
in CHCl3), Zn2FAM (0.2 mM in MeOH), CuTMR (0.2 mM in CHCl3), Zn2BC (1 mM in 
MeOH) and FAM (1 mM in CHCl3) were mixed. The solvent was completely removed 
under reduced pressure at 25 °C and an appropriate amount of buffer (HEPES 25 mM, 
pH 7.4) was added to obtain lipid concentrations of 1 mM. Vigorous shaking (900 min-1) at 
35 °C (DMPC) or 50 °C (DPPC) for 10 min yielded a turbid multi-lamellar vesicle 
suspension. Small uni-lamellar dispersions were obtained by extrusion through 100 nm-
pore size polycarbonate membranes with a LiposoFast liposome extruder from Avestin. 
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Metal complex concentration 
For all vesicles the receptor concentration refers to the outer surface exposed binding 
sites, as only these should be reactive, with the assumption that embedded compounds 
distribute equally in both layers of the vesicle membrane and the bilayer thickness for the 
prepared vesicles amounts to 5 nm.45-48 This corresponds to a surface correction factor of 
0.54 (only 54% of membrane embedded molecules is at the outer surface) to give surface 
accessible concentrations of Zn2FAM (4 x 10
-7 mol/L) and CuTMR (4 x 10-7 mol/L) in V1 
or Zn2BC (5.4 x 10
-8 mol/L) and FAM (5.4 x 10-8 mol/L) in V2. Assuming that one bivalent 
analyte (P1) is binding to two receptor molecules (Zn2BC), one equivalent of P1 is 
2.7 x 10-8 mol/L in relation to V2. 
Dynamic light scattering (DLS) 
Vesicle size distributions were determined using dynamic light scattering (DLS). Vesicle 
V2 (DMPC 1 x 10-5 mol/L, Zn2BC 1 x 10
-7 mol/L and FAM 1 x 10-7 mol/L) was incubated 
after addition of P1 (2.7 x 10-8 mol/L) at 35 °C and cooled down to 10 °C before SEC. No 
significant change in size distribution was determined after imprinting compared with the 
typical size distribution of an extruded vesicle sample (Figure S1). Average size 
distribution of about 110 nm and monodispersity (polydispersity index = 0.16) were 
achieved. 
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Figure S1. Size distribution of imprinted vesicles V2 (red) is comparable with initial vesicle 
solutions (black). Analyte binding to V2 (green) and temperature alteration changes size 
distribution only marginal. Average size of monodispers imprinted vesicles is about 110 nm 
(polydispersity index =  0.16). 
 
FRET measurements 
Receptor organization in the liquid-crystalline phase of DOPC membranes, which is 
induced by an external bivalent analyte and monitored by a significant change of the 
FRET emission, was previously established by us.40 Based on these investigations it was 
shown that a template guided receptor orientation can be transferred from the liquid 
crystalline phase into the gel phase of a vesicular membrane by lowering the temperature 
below the phase transition temperature. This receptor assembly is stronger than phase 
separation in the gel phase of vesicles.  Fluorescence intensity and therefore FRET 
emission is, next to the spatial distance of dyes, also dependent on the temperature. 
Hence it is not possible to compare FRET signals monitored at different temperatures. 
Therefore we detect FRET ratio (I580nm / I520nm) before and after analyte addition at different 
temperatures. The change of FRET ratio (FRET ratio) is the difference between the 
FRET ratio in the presence of a binding partner and the FRET ratio without analyte. This 
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value is used to estimate the degree of analyte guided receptor arrangement below and 
above TM.  
 A 1 x 0.2 cm2 quartz cuvette was filled with 50 µL of a vesicles solution V1 (TM = 41 °C, 
DPPC 1.33 x 10-4 mol/L, Zn2FAM 1 x 10
-6 mol/L and CuTMR 1 x 10-6 mol/L in HEPES 
25 mM, pH 7.4) and cooled to 10 °C with temperature control of the Horiba “Fluoromax4”. 
Afterwards either 50 µL analyte P1 (2 x 10-3 mol/L in water) or 50 µL water (as reference), 
both incubated at 10 °C, were added. Previous investigations showed that hexapeptides 
with only one or no binding moiety do not cause bivalent receptor rearrangement of 
Zn2FAM and CuTMR in DOPC vesicles.
40 The FAM-label of V1 was excited at 485 nm 
and FRET emission, with typical maxima at 520 nm and 580 nm, was monitored at 10 °C 
(Figure S2, Top). No receptor recruitment of P1 was detected below TM and FRET 
signaling of the analyte equipped sample is even weaker.v 
The same vesicle solutions were heated up to 50 °C (in spectrometer with temperature 
control for 2 min). Analyte triggered receptor rearrangement is detected by a significant 
increase of the FRET ratio observed for V1 in the presence of suitable analytes, which is 
in accordance to previous investigations.40 Subsequently the cuvettes were cooled for 
1 min in an ice bath, before they were incubated for 2 min at 10 °C in the spectrometer. 
The orientation of FRET labeled receptors was transferred to the gel phase membrane of 
V1, as indicated by unchanged FRET ratio values (Figure S2, Bottom). Cooling the 
vesicles from the liquid crystalline to the gel phase did not lead to a phase separation of 
the template arranged receptors in the membrane for at least 10 min. 
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Figure S2. Top: FRET emission of V1 in the presence and the absence of P1 at 10 °C (left), 50 °C 
(middle) and 10 °C (right) after cooling. Bottom: The FRET ratio (left) was calculated from the 
emission spectra (see above). FRET ratio (right) compares the spatial assembly of receptors in 
the presence and the absence of P1 (*results recorded after 10 min). 
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Molecular imprinting procedure 
A procedure for molecular imprinting on vesicular surfaces by photo crosslinking was 
recently published by us.27 This technique was modified to investigate the imprinting by 
non-covalent thermal changes. DMPC vesicles (TM = 24 °C) were functionalized with the 
amphiphilic receptor Zn2BC, which binds to imidazole and phosphate moieties of P1 and 
an amphiphilic fluorescent dye (FAM) monitoring the binding. Vesicle solutions V2 (DMPC 
1 x 10-5 mol/L, Zn2BC 1 x 10
-7 mol/L and FAM 1 x 10-7 mol/L) were filled in 1 x 0.4 cm2 
quartz cuvettes (1 mL) and incubated for 10 min at 35 °C, in order to prepare imprinted 
vesicles, or kept at 10 °C as reference sample. The template peptide P1 (2.7 x 10-8 mol/L) 
was added to both solution and the temperature was maintained for additional 10 min. 
Both solutions were cooled in an ice bath for 1 min, followed by incubation at 10 °C for 
further 10 min. The vesicle solutions were passed through a SEC column at 10 °C to 
remove the template peptide P1 below TM. The obtained vesicle solutions were kept at 
10 °C for 15 min before binding affinity was determined by titration. 
 
Size exclusion chromatography (SEC) 
Template peptides P1 (2.7 x 10-8 mol/L) were removed from the vesicle solutions below 
TM by size exclusion chromatography (SEC) using small spin columns.
49 Sephadex G-25 
SEC medium was swollen in HEPES buffer (25 mM, pH 7.4) for 24 h prior to use. The 
sephadex solution (2.5 mL per mL vesicle solution) was transferred into a small plastic 
syringe with filter and the solvent was removed by centrifugation in an Eppendorf bench 
top centrifuge with temperature control (15 s @ 4400 rpm, 5 °C). Vesicles solutions were 
added onto the column and filtered by centrifugation (15 s @ 4400 rpm, 5 °C). 
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Differential scanning calorimetry (DSC) 
DSC measurements confirmed that the phase transition temperature of V2 was not 
changed by embedding 1 mol% of receptor and dye (each) in the DMPC membrane. TM of 
DMPC vesicles is 24 °C.42, 43 A sealed aluminum pan was filled with 11.2 mg V2 (DMPC 
1 x 10-3 mol/L, Zn2BC 1 x 10
-5 mol/L and FAM 1 x 10-5 mol/L) and DSC was measured in a 
Perkin Elmer DSC 8000 from 15 °C to 35 °C with a heat rate of 1 K min-1 under 
N2-atmosphere in three reversible cycles (Figure S3). A phase transition temperature of 
24 °C was found for functionalized vesicle V2. The value is identical to the TM of DMPC 
vesicles. 
 
Figure S3. DSC measurement records a phase transition temperature of V2 at 24 °C.  
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Rebinding studies 
Vesicle solutions V2 (DMPC 1 x 10-5 mol/L, Zn2BC 1 x 10
-7 mol/L and FAM 1 x 10-7 mol/L) 
obtained from the thermal imprinting procedure and removal of the template by SEC were 
titrated with P1 under temperature control (10 °C). The change of fluorescence emission 
(excitation of FAM at 485 nm, emission maximum at 520 nm) was determined (Figure S4, 
Figure S5) and binding constants were calculated by non-linear fitting of the experimental 
data using the Hill equation (Figure 2, Results & Discussion). All measurements were 
repeated three times and the estimated error in determining the binding constant values is 
± 0.2. Previous investigations proved that hexapeptides with only one or no binding moiety 
do not show bivalent binding to imprinted Zn2BC, coembedded to FAM, in 
photocrosslinked DOPC vesicles.27 
 
Figure S4. FAM emission (ex = 485 nm, em = 520 nm) upon P1 addition to imprinted V2. 
 
Figure S5. FAM emission (ex = 485 nm, em = 520 nm) upon P1 addition to non-imprinted V2. 
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The observed binding of imprinted vesicles V2 to P1 is different in comparison to the non-
imprinted vesicles of identical composition. A positive cooperativity (n = 1.4) is observed 
for imprinted V2 in the Hill equation fitting of the spectroscopic data, whereas non-
imprinted vesicles lead to a negative cooperativity (n = 0.8). The emission intensity 
change up to one equivalent of added P1 is more pronounced for the imprinted vesicle 
indicating the preorganization (Figure S4). Upon addition of more than one equivalent of 
P1 the difference in binding stoichiometry becomes visible. While P1 binds to imprinted 
vesicles up to one equivalent in a 1:1 fashion, and only if an excess of P1 is added a 
second saturation now with 2:1 stoichiometry is reached (Figure S6, left). Non-imprinted 
vesicles show no change in binding stoichiometry during the titration (Figure S6, right). A 
similar effect for DOPC vesicles was recently observed.40 
 
Figure S6. Job’s Plot (limiting reagent method) of P1 versus imprinted V2 (left) and non-imprinted 
V2 (right). 
2 
Thermally Induced Molecular Imprinting of Luminescent Vesicles 
 
 
 61 
 
Erasing of imprinted surface patterns 
Imprinted vesicle solutions V2 (DMPC 1 x 10-5 mol/L, Zn2BC 1 x 10
-7 mol/L, FAM 
1 x 10-7 mol/L) were heated above TM (at 35°C) after template removal for 15 min, before 
they were used for rebinding studies with P1 (Figure S7). Phase transition of imprinted 
vesicles will cause a deletion of template guided receptor patterning. Hence a loss of 
rebinding affinity is detected, leading to a log K = 7.4 (imprinted V2: log K = 8.2). 
 
Figure S7. Hill equation fit of the binding data show a loss of the imprinting of V2 after heating 
above TM. 
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Imprinting of DPPC vesicles 
Vesicle solutions V3 (TM = 41 °C, DPPC 1 x 10
-5 mol/L, Zn2BC 1 x 10
-7 mol/L and FAM 
1 x 10-7 mol/L) were prepared and incubated with peptide P1 (2.7 x 10-8 mol/L) at either 
65 °C (imprinted V3) or at 21 °C (non-imprinted V3) analogously to the above procedure. 
Solutions were cooled to 21 °C and the template P1 removed by SEC. 
Titration with P1 in a rebinding study revealed by non-linear fitting a log K = 8.0 for 
imprinted V3 and a log K = 7.3 for the non-imprinted sample. (Figure S8). 
 
Figure S8. Top: FAM emission (ex = 485 nm, em = 520 nm) upon P1 addition to imprinted DPPC 
vesicles V3 (left) and non-imprinted V3 (right). Bottom: Hill fit of binding curve for V3. 
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Notes and References 
i
 Note: Fluorescence intensity and therefore FRET emission is temperature dependent. Hence 
it is not possible to compare FRET signals monitored at different temperatures. Therefore we 
determine the FRET ratio (I580nm / I520nm) before and after analyte addition at different 
temperatures. The change of FRET ratio (FRET ratio) is the difference between FRET ratio 
in the presence of a binding partner and the FRET ratio without analyte. This value is used to 
estimate the degree of analyte guided receptor arrangement below and above TM. 
 
ii
 FRET emission intensities were not changing during 10 min after cooling V1 to 10°C. 
 
iii
 We previously reported the covalent molecular imprinting by photopolymerization using the 
same receptor – ligand pair (see ref. 27). 
 
iv
 Rebinding of P1 with a value of log K = 8.0 for imprinted and a value of log K = 7.3 for non-
imprinted DPPC vesicles (TM = 41°C) was determined analogously. 
 
v
 This may be caused by a less strong clustering of analyte-bound receptors. 
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CHAPTER 3 
TERBIUM(III)-CHOLATE FUNCTIONALIZED VESICLES AS LUMINESCENT 
INDICATORS FOR THE ENZYMATIC CONVERSION OF 
DIHYDROXYNAPHTHALENE DIESTERS 
 
 
 
 
The phosphorescence intensity of unilamellar DOPC vesicles with embedded Tb3+-cholate 
complexes depends on the concentration of dihydroxynaphthalene (DHN) as sensitizer in 
solution. This was used to monitor the enzymatic conversion of DHN esters or DHN 
glucosides by enzymes in aqueous buffered solution. 
 
This Chapter has been published: 
S. Balk, U. Maitra, B. König, Chem. Commun., 2014, 50, 7852–7854. 
Author contributions: 
SB synthesized vesicles, performed measurements and wrote the manuscript; UM and BK 
supervised the project and are corresponding authors. 
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Introduction 
Cholic acids are known to aggregate in the presence of trivalent lanthanide ions resulting 
in three dimensional networks of hydrogels.1-4 Such gels have found applications as 
optical materials,1, 2, 5-7 in the preparation of nanoparticles,3, 8 as confined reaction media9, 
10 and in the detection of analytes.11-14 The lanthanide luminescence of hydrogels 
prepared from sodium cholate and terbium(III) salt is sensitized by 
2,3-dihydroxynaphthalene (DHN). Only the dihydroxy compound coordinates to the 
Tb3+ ion and acts as sensitizer, but not DHN ester or acetal derivatives.1 This observation 
has been used to monitor the enzymatic conversion of carboxy esters or the 
monoglucoside of DHN by changes in the phosphorescence intensity avoiding 
interference with background fluorescence.15-19; 20-22 The luminescent gel indicator is 
prepared by self-assembly of all components in aqueous buffer, but the three dimensional 
gel limits the diffusion and the enzymes have to be added during gel preparation. 
Therefore we transferred this detection mechanism from hydrogels to the membrane of 
small unilamellar vesicles (Scheme 1). Functionalized lipid bilayers have been previously 
used in enzyme assays23-25 or as luminescent indicators.26-29 
 
Results and Discussion 
A vesicular solution of 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC, 5 mM) in 
HEPES buffer (25 mM, pH 7.4), was prepared by extrusion in the presence of a 
submicellar concentration‡ of cholic acid (0.75 mM). The cholic acid will phase separate in 
the DOPC membrane and added TbCl3*6 H2O (0.25 mM) coordinates to the membrane 
embedded bile salts. Alternatively, a post functionalization of DOPC vesicles by bile salts 
and Tb(III) is possible, when the components are added to buffered DOPC vesicle 
solutions. We assume the formation of membrane anchored terbium(III)-complex 
domains. The resulting vesicle solutions are homogeneous, stable and monodispers. 
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Scheme 1. Self assembly of amphiphiles (DOPC) and cholates in aqueous solution yields gel-
functionalized small unilamellar vesicles after extrusion. The addition of dihydroxynaphthalene 
(DHN), which is coordinating to the metal complex, sensitizes the Tb
3+
- luminescence. 
Next, DHN (12.5 µM) was added to the aqueous vesicle solution Vs1 (c(DOPC) = 5 mM, 
c(Chol) = 0.75 mM). Excitation of the mixture at 335 nm gave a significant terbium 
luminescence with an emission maximum at 545 nm (Scheme 2). Previous studies have 
shown that the DHN sensitization of the lanthanide emission requires a rigid gel matrix.1, 11 
The strong increase of terbium luminescence in the vesicle membrane therefore indicates 
that the Tb3+-cholate patches might have gel like properties. 
 
Scheme 2. Excitation of DHN at 335 nm in a cholate doped vesicle solution results in a strong 
Tb
3+
- phosphorescence emission (green); without sensitizer (blue) the terbium luminescence is 
weak; no emission is detected for cholate-vesicles (red). 
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The presence of cholic acid, DHN and terbium (III) salts as membrane additives is 
essential to observe the lanthanide emission (Scheme 2), which was confirmed by 
different DOPC vesicle solutions (Vs2: c(DOPC) = 5 mM, Vs1: c(DOPC) = 5 mM, 
c(Chol) = 0.75 mM, Vs3: c(DOPC) = 5 mM, c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM, 
c(DHN) = 12.5 µM) and post functionalized DOPC vesicles (Vs3p: c(DOPC) = 5 mM, 
c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM, c(DHN) = 12.5 µM). Dynamic light scattering (DLS) 
confirmed a monodispers narrow size distribution around 110 nm for all samples. In 
contrast, solutions of cholate monomers (0.75 mM) in HEPES buffer (25 mM, pH 7.4) or 
CHCl3 showed a broad size distribution and polydispersity (see SI for data). The 
embedding of the luminescent cholic acid – terbium complexes in the vesicle membrane 
was confirmed by fluorescence anisotropy: The terbium complex, excited by DHN 
(12.5 µM) at 335 nm, and bound to cholic acid doped vesicles Vs4 (c(DOPC) = 5 mM, 
c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM) showed a fluorescence anisotropy, detected at 
550 nm, which is about 8 times higher than for terbium in aqueous cholic acid solution 
(c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM, c(DHN) = 12.5 µM). Higher anisotropy values detected 
at 380 nm of DHN (12.5 µM) in the presence of Vs4 compared to aqueous cholate 
solution indicated the coordination of DHN to terbium(III) ions at the surface of vesicle Vs4 
(see SI for data). 
Since DHN derivatives lacking free hydroxy groups for metal coordination, do not sensitize 
the terbium(III) emission, reactions converting DHN derivatives into DHN can be easily 
monitored by the functionalized vesicles. Lipase (Candida rugosa, 2.5 U/mg, 50 mg/L) 
was added to the aqueous vesicle solution Vs1 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM) with 
added TbCl3 * 6 H2O (0.25 mM) and naphthalene- 2,3,-diyl dihexanoate (DHNdhn, 
12.5 µM) or naphthalene-2,3-diyl diacetate (DHNdac, 12.5 µM). The enzymatic ester 
cleavage of DHNdhn into DHN leads to an increase of the vesicle luminescence intensity 
tracing the reaction (Scheme 3 and 4). 3-Hydroxynaphthalene-2-yl--glucoside (DHNglu, 
12.5 µM) was likewise used to monitor the enzymatic activity of -glucosidase (from 
almonds, 6.5 U/mg, 50 mg/L). 
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Scheme 3. Lipase conversion of naphthalene-2,3-dihydroxyesters (12.5 µM) into DHN leads to an 
increase of the terbium luminescence intensity. 
 
Scheme 4. Luminescence intensity of Vs4 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM) is 
increasing in the presence of DHNdhn (12.5 µM) and lipase (50 mg/L) over 24h. 
To confirm that the emission intensity change during the reaction correlates with the 
amount of produced DHN, we monitored the enzymatic conversion by HPLC in the 
absence of vesicles. The initial rate constants for the esterase activity of lipase derived 
from the emission intensity increase or the HPLC analysis of produced DHN were 
comparable with 1.3 x 10-8 and 1.9 x 10-8 mmol/min, respectively, (see SI for data).‡‡ A 
detection limit of 0.5 mg/L for lipase activity was determined for the assay using a 24 h 
incubation time, which significantly improved compared to the previously used hydrogels 
that required 900 mg/L.5a 
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Conclusion 
In conclusion, we have embedded terbium – cholate aggregates into the membrane of 
100 nm unilamellar DOPC vesicles. Dihydroxynaphthalene coordinates to the complexes 
at the membrane-water interface and sensitizes the terbium phosphorescence. As the 
concentration of free dihydroxynaphthalene in the aqueous solution correlates with the 
terbium phosphorescence intensity, enzymatic reactions of dihydroxynaphthalene esters 
and glycosides can be monitored in buffered aqueous solution. The phosphorescent 
vesicular indicator is easily prepared by self-assembly and many DHN derivatives as pro-
sensitizers can be envisaged that are suitable substrates for a variety of enzymes. The 
detection principle may therefore find application as a facile luminescent on-line 
monitoring of enzymatic activity. 
SB thanks the INDIGO network of the German Academic Exchange Service (DAAD) for 
travel support. 
 
Experimental Part and Supporting Information 
General methods and material 
Fluorescence measurements were performed with UV-grade solvents (Baker or Merck) in 
1.0 or 0.4 cm quartz cuvettes (Perkin Elmer / Hellma) and recorded on a Horiba 
Fluoromax4 spectrophotometer with temperature control at 20 °C. Phosphorescence 
measurements were recorded on a Varian ‘Cary Eclipse’ fluorescence spectrophotometer 
(total decay time: 0.020 s, delay time 0.1 ms, gate time 5.0 ms, slit 20 nm) with 
temperature control (20 °C) using 1 cm quartz cuvettes (Hellma). DLS measurements 
were performed on a Malvern Zetasizer Nano at 20 °C using 1 cm disposable polystyrene 
cuvettes (VWR). Starting materials were used without any further purification. 
Phospholipids were purchased from Avanti Polar Lipids Inc. Commercially available 
solvents of standard quality and water of millipore quality were used. Naphthalene- 2,3,-
diyldihexanoate (DHNdhn) synthesis is described in the Ph.D. thesis of Mr. Sandip 
Bhowmik "Design and Applications of Bile-salt/Lanthanide based Hydrogels", Indian 
Institute of Science, Bangalore, February 2013. Naphthalene- 2,3,-diyl diacetate 
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(DHNdac) and 3-hydroxynaphthalene-2-yl- b-glucoside (DHNglu): synthesis is described 
in the supporting information of Chem. Commun., 2012, 48, 4624 (Sandip Bhowmik, Uday 
Maitra). Candida rugosa lipase was obtained from Sigma-Aldrich (2.5 Units/mg; catalogue 
no. 90860-5G and Batch no. 445584/1). Beta-glucosidase from almonds was obtained 
from Sigma-Aldrich (6.5 Units/mg; catalogue no. 49290-250 MG and Batch no. 
BCBD2305V). TbCl3 * 6 H2O was obtained from Sigma Aldrich (catalogue no. 212903-5G, 
batch no. MKBD6300V). Time dependent enzyme conversions were measured via HPLC 
analysis on a Agilent 1290 Series HPLC: Column: Phenomenex Luna C18, 3 µm, 
150 x 2.00 mm, 100 Å; flow: 0.3 mL/min; solvent A: H2O [0.059 Gew% TFA], solvent 
B: MeCN; gradient: 0-20 min: A/B 97/3, 20-30 min: A/B 2/98. 
 
Vesicles 
Preparation 
In small glass reaction vessels 1 - 5 µmol of DOPC or DSPC were dissolved in chloroform 
and optionally 15 mol% of dissolved sodium cholate was added and mixed. The solvent 
was completely removed under reduced pressure at 25 °C (DOPC) or 75˚C (DSPC) and 
an appropriate amount of buffer (HEPES 25 mM, pH 7.4) was added to obtain lipid 
concentrations of 5 mM. Vigorous shaking at 25 °C (DOPC) or 75 °C (DSPC) for 10 min 
yielded a turbid multi-lamellar vesicle suspension. Small uni-lamellar dispersions were 
obtained by extrusion through 100 nm-pore size polycarbonate membranes with a 
LiposoFast liposome extruder from Avestin. DOPC- cholate vesicles were equipped with 
5 mol% of aqueous TbCl3 * 6H2O and stored for 10 min to ensure cholate - terbium- 
complexation. Alternative pure DOPC vesicles were post functionalized with an 
appropriate amount of cholate and after 10 min TbCl3 * 6 H2O was added. In order to 
induce a luminescent response of Tb3+- gel functionalized vesicle solutions 
2,3-dihydroxynaphthalene (DHN) was added. 
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Dynamic light scattering (DLS) 
Vesicle size distributions were determined using dynamic light scattering (DLS). Vesicle 
Vs1 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM) was functionalized with Tb
3+ (0.25 mM) and DHN 
(12.5 µM), which induced no change in the size distribution. This indicates that no 
aggregates beside vesicles with an average size distribution of about 110 nm are present. 
 
Scheme S1. Size distribution of Vs1 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM; red) before and after 
functionalization with Tb
3+
 (0.25 mM; blue) and additional DHN (12.5 µM; green). 
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For comparison, solutions of Chol (0.75 mM) in HEPES (25 mM, pH 7.4) and CHCl3 have 
been prepared in the presence of DHN (12.5 µM) before treatment with Tb3+ (0.25 mM). 
The particle size distribution of these solutions is not reproducible, has a high 
polydispersity index and indicates agglomeration of bile salts in aqueous and organic 
solvents. 
 
Scheme S2. Size distribution of Chol solutions (c(Chol) = 0.75 mM; red) with DHN (12.5 µM) in 
HEPES (green) and CHCl3 (blue). After addition of Tb
3+
 (0.25 mM) to HEPES- Chol solution (red) 
and CHCl3- Chol solution (black) an enlargement of aggregates is assumed. 
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The DOPC vesicle solution Vs2 (c(DOPC) = 5 mM) was post functionalized with cholic acid 
(0.75 mM), Tb3+ (0.25 mM) and DHN (12.5 µM) giving a monodispers size distribution of 
vesicles. 
 
Scheme S3. Size distribution of Vs2 (c(DOPC) = 5 mM; red) after addition of cholate (0.75 mM, 
green). 
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The aggregation of Chol (0.75 mM) in HEPES (25 mM, pH 7.4) or CHCl3 after treatment 
with Tb3+ (0.25 mM) was obvious after a few minutes. In contrast, Vs1 (c(DOPC) = 5 mM, 
c(Chol) = 0.75 mM) functionalized with Tb
3+ (0.25 mM) remains a homogeneous 
monodispers solution.  
 
Figure S1. Solution of Vs1 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM; left) doped with Tb
3+
 (0.25 mM) 
yields a homogeneous monodispers solution. Chol- Tb
3+
 solutions in HEPES (25 mM, pH 7.4; 
middle) and CHCl3 (right) indicate aggregate formation. 
 
Fluorescence Anisotropy 
The embedding of the luminescent cholic acid – terbium complexes in the vesicle 
membrane was confirmed by fluorescence anisotropy. The terbium complexes 
(c(Tb
3+
) = 0.25 mM) are excited by DHN (12.5 µM) at 335 nm and are bound to cholic acid 
doped vesicles Vs4 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM) as they show a 
fluorescence anisotropy (Scheme S4, right; FA = 0.23), detected at 550 nm, which is 
about 8 times higher than for terbium in aqueous cholic acid solution (FA = 0.06; 
c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM, c(DHN) = 12.5 µM). Higher anisotropy values are 
detected at 380 nm for DHN (12.5 µM) with Vs1 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM) 
(Scheme S4, left; FA = 0.34) or in presence of 0.25 mM Tb3+ (Scheme S4, middle; 
FA = 0.33) than for aqueous cholate solutions (Scheme S4, left, c(Chol) = 0.75 mM, 
FA = 0.06 and middle c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM, FA = 0.03) indicate that DHN 
(12.5 µM) coordinates to the terbium(III)- cholate complex at the liposome membrane. 
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Scheme S4. Fluorescence anisotropy of DHN at 380 nm (left and middle) and Tb
3+
 at 550 nm 
(right) with cholate doped vesicles (green) is significant higher compared to aqueous solutions of 
Chol (red). 
 
Phosphorescence measurements 
Only terbium(III), which is complexed by cholate functionalized vesicles, shows intensive, 
significant terbium phosphorescence at 545 nm after excitation of coordinated DHN 
sensitizer at 335 nm. 
A significant increase of terbium phosphorescence intensity at 545 nm of Vs4 
(c(DOPC) = 5 mM, c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM) was detected during the conversion 
of DHNdhn (12.5 µM) by lipase (50 mg/L) for 24 h. DHN is, in contrast to its ester 
derivative, coordinating with its dihydroxy moiety to the vesicular embedded, cholate 
complexed terbium, which provides an effective sensitization at 335 nm (see fluorescence 
anisotropy Scheme S4, left). 
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Enzyme activity assay 
The emission intensity of Vs4 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM) was 
monitored over 24 h in a cuvette (2 x 10 mm, 400 µL) at 545 nm in the presence of the 
respective DHN derivative (c(DHN’) = 12.5 µM) and enzyme (50 mg/L lipase or glucosidase). 
(Scheme S5 and S7). Due to the higher sensitivity of the spectrometer, fluorescence 
emission intensity instead of phosphorescence intensity was used for the comparison with 
HPLC analysis of DHN. 
The respective DHN derivative (c(DHN’) = 12.5 µM) and enzyme (50 mg/L lipase or 
glucosidase) are incubated in a HEPES buffer solution (25 mM, pH 7.4), lacking any 
cholate doped vesicles or Tb3+, over 24 h. Samples were analyzed by calibrated HPLC to 
monitor the evolving DHN amount over time. 
 
Scheme S5. Fluorescence intensity increase of Vs4 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM, 
c(Tb
3+
) = 0.25 mM) upon conversion of DHNdhn (12.5 µM) with lipase (50 mg/L) during 24h (left). 
DHNdhn conversion by lipase was monitored by fluorescence intensity changes of Vs4 and HPLC 
analysis (right). 
The initial rate constants for the lipase activity, derived from the fluorescent increase or 
the HPLC analysis of DHNdhn, are with 1.3 x 10-8 and 1.9 x 10-8 mmol/min, resp., 
comparable (Scheme S5). In order to correlate fluorescence intensity with the DHN 
concentration, increasing amounts of DHN were added to Vs4 (Scheme S6). The slope of 
enzyme conversion (mmol/min) (Scheme S5, right) was detected during the first 60 min 
with an intensity increase from 1.8 x 106 to 3.1 x 106 cps. The value corresponds to the 
linear region of fluorescence intensity vs. sensitizer amount (Scheme S6, right). 
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Scheme S6. Increasing fluorescence intensity of Vs4 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM, 
c(Tb
3+
) = 0.25 mM) upon addition of DHN (left). Fluorescence intensity increases linearly for small 
sensitizer concentrations (right), which were used to monitor enzyme activity. 
 
Scheme S7. Change of the terbium fluorescence intensity (left y-axis) of Vs4 (c(DOPC) = 5 mM, 
c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM) during the conversion of DHNdac (12.5 µM) by lipase (50 mg/L) 
(left) and DHNglu (12.5 µM) by glucosidase (50 mg/L) (right). For comparison monitoring of the 
DHN conversion by HPLC is given on the right y-axis. 
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To exclude a potential inhibition of the enzyme activity in the presence of terbium ions,30, 31 
we monitored the DHNdhn (12.5 µM) conversion with lipase (50 mg/L) by HPLC in 
presence and absence of Tb3+ (0.25 mM). The conversion of the DHNdhn is comparable 
in both cases, though the amount of free DHN in solution detected by HPLC is little lower 
in the presence of Tb3+ (Scheme S8). However, this is not caused by inhibition of the 
lipase activity, but by the coordination of DHN to the lanthanide cation. The complex is not 
detected by HPLC. Moreover the measured amount of DHN is even lower for an equal 
DHNdhn lipase sample which was treated with Tb3+ (0.25 mM) only shortly before HPLC 
or for a sample, equipped with Tb3+ (0.25 mM) and cholate (0.75 mM), showing 
precipitation (Scheme S8, inset). The coordination of DHN towards Tb3+ was also 
observed with fluorescence anisotropy measurements of DHN (Scheme S4, red columns 
left and middle). Hence the presence of Tb3+ does not affect the enzymatic conversion 
and provides unambiguous enzyme activity detection with fluorescence emission and 
HPLC (Scheme S5, right and S7). 
 
Scheme S8. HPLC analysis confirms that the enzymatic conversion of DHNdhn (12.5 µM) is not 
inhibited by the presence of terbium ions (0.25 mM). Changing concentrations of HPLC detectable 
DHN in solution in presence of terbium is a result of complex formation, which masks the DHN for 
HPLC analysis. 
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Control experiments (Scheme S9) show no significant fluorescence intensity increase of 
Vs4 (c(DOPC) = 5 mM, c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM) in the presence of a DHN 
derivate (12.5 µM) without enzymes after 24 h. 
 
Scheme S9. Increase of emission intensity of Vs4 over time in the presence of DHN esters in the 
presence and in the absence of enzymes. 
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A detection limit of 0.5 mg/L for lipase enzymatic activity was determined with Vs4 
(c(DOPC) = 5 mM, c(Chol) = 0.75 mM, c(Tb
3+
) = 0.25 mM) for the previous described assay 
(lipase 50 mg/L) with reduced amounts of enzyme using 24 h incubation time. 
 
Scheme S10. The limit of detection of lipase activity assay with DHNdhn and Vs4 is 0.5 mg/L; 1 % 
of the enzyme standard solution (50 mg/L). 
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SUMMARY  
This work describes the membrane functionalization of small unilamellar phospholipid 
vesicles by incorporation of artificial amphiphiles. The presented investigations 
demonstrate a fast and simple approach for sensing molecular recognition events at the 
membrane-water interface. 
Chapter 1 describes the dynamic recognition of multivalent ligands by receptor recruiting 
in fluid vesicle membranes. Two amphiphilic metal-complexes with attached FRET-pair 
labels were prepared and embedded into DOPC vesicles. Simultaneous binding of a 
model peptide enables receptor recruiting at the liquid-crystalline liposome membrane and 
a significant increase in energy transfer was observed as the two fluorescence labels 
come into close proximity. 
Chapter 2 presents the approach of thermal imprinting by non-covalent assembly of 
metal-complexes embedded in DMPC vesicles. Template induced patterning in the liquid-
crystalline phase was reversibly stabilized by phase transition of the liposomal membrane 
to the gel phase as shown by FRET measurements. Specific rebinding of thermally 
imprinted vesicular receptors to the bivalent target peptide provides an affinity 
enhancement after template removal. 
In Chapter 3, terbium-cholate aggregates were used to functionalize DOPC vesicles. The 
phosphorescence intensity of these gel-like liposomal Tb3+-patches depends on the 
concentration of DHN as sensitizer in solution. Based on this result a novel enzymatic 
assay was established to monitor the conversion of DHN esters or DHN glucosides by 
enzymes in aqueous solutions. 
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ZUSAMMENFASSUNG 
In der vorliegenden Arbeit wurden selbstorganisierte Membranen von unilamellaren 
Phospholipid-Vesikeln durch Einlagerung synthetischer Amphiphile funktionalisiert. Die 
aufgezeigten Untersuchungen demonstrieren eine schnelle und einfache Methode zur 
Detektion molekularer Erkennungsvorgänge an der Grenzfläche von Membran und 
Wasser. 
Kapitel 1 beschreibt die Erkennung multivalenter Liganden mittels dynamischer 
Strukturierung von Bindungsstellen in fluiden Vesikelmembranen. Dazu wurden zwei 
amphiphile Metallkomplexe mit FRET-komplementären Fluoreszenzlabeln synthetisiert 
und in DOPC-Vesikel eingebaut. Die gleichzeitige spezifische Koordination eines 
Modellproteins an beide Bindungsstellen ermöglicht die Umstrukturierung der Rezeptoren 
in der flüssig-kristallinen Phase der Liposomen. Dabei wurde ein signifikanter Anstieg des 
Energietransfers aufgrund der geschaffenen räumlichen Nähe der Fluoreszenzlabel 
festgestellt. 
Kapitel 2 demonstriert die Methode des thermischen Imprintings durch nicht-kovalentes 
Anordnen von Metallkomplexen in DMPC-Vesikel. Die Templat-induzierte Strukturierung 
in der flüssig-kristallinen Phase wurde durch Phasenumwandlung der Vesikelmembran 
reversibel fixiert und durch FRET-Messungen nachgewiesen. Die spezifische erneute 
Bindung des bivalenten Zielpeptids durch Vesikel mit thermisch geprägten Rezeptoren 
erzielt nach Abtrennung des Templats eine höhere Affinität. 
In Kapitel 3 wurden Terbium-Cholat-Komplexe für die Funktionalisierung von DOPC-
Vesikel benutzt. Die Phosphoreszenzintensität dieser gelähnlichen Tb3+-Strukturen ist 
abhängig von der DHN-Konzentration welche zur photochemischen Anregung in der 
Lösung verwendet wird. Dies bildet die Grundlage für einen neuen Enzymassay, welcher 
den Umsatz von DHN Estern oder DHN Glucosiden durch Enzyme in wässriger Lösung 
nachverfolgt.  
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ABBREVIATIONS 
AES  
AFM 
Aq  
Ar  
Bipy  
Boc  
BSA  
c  
calcd  
Cbz  
CF  
Chol 
CI  
COSY 
cyclen  
d  
DAD  
DCC  
DCM  
DEA  
DET  
DHN 
DHNdac 
DHNdhn 
DHNglu 
DIPEA  
DLS  
DMAP  
DMF  
DMPC  
DMSO  
Atomic emission spectroscopy 
Atomic force microscopy 
Aqueous 
Aryl 
Bipyridine 
tert-Butyloxycarbonyl 
Bovine serum albumin 
Concentration 
Calculated 
Benzyloxycarbonyl 
Carboxyfluorescein 
Cholic acid 
Chemical ionization 
Correlated spectroscopy 
1,4,7,10-tetraazacyclododecane 
Day(s) 
Diode array detector 
Dicyclohexylcarbodiimide 
Dichloromethane 
Diethylamine 
Diethylenetriammonium 
2,3-dihydroxynaphthalene 
Naphthalene-2,3-diyl diacetate 
Naphthalene- 2,3,-diyl dihexanoate 
3-hydroxynaphthalene-2-yl--glucoside 
Diisopropylethylamine 
Dynamic light scattering 
4-(dimethylamino)-pyridine 
Dimethylformamide 
1, 2-dimyristoyl-sn-glycero-3-phosphocholine 
Dimethylsulfoxide 
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DOPC  
DP  
Dpa  
DPPC  
DSC  
DSPC  
EA  
EDC  
EI-MS  
eq  
ES-MS  
Et  
EtOAc  
EtOH  
FA 
FAB  
FAM  
FRET  
h  
HBTU  
 
HEPES  
His  
HOBt  
HPLC  
HRMS  
HSQC  
ICP  
IR  
ITC  
J  
LB  
Me  
1,2-dioleoyl-sn-glycero-3-phosphocholine 
Di-picolyl 
Di-(2-picolyl)amine 
1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
Differential scanning calorimetry 
1,2-distearoyl-sn-glycero-3-phosphocholine 
Ethylacetate 
N-(3-Dimethylamino-propyl)-N’-ethylcarbo-diimide 
Electron-impact ionization mass spectrometry 
Equivalents 
Electrospray ionization mass spectrometry 
Ethyl 
Ethylacetate 
Ethanol 
Fluorescence Anisotropy 
Fast-Atom-Bombardment 
Carboxyfluorescein 
Fluorescence resonance energy transfer 
Hour 
2-(1H-Benzotriazole-1-yl)-1,1,3,3-tetramethyl-uronium 
hexafluorophosphate 
N-2-Hydroxy-ethylpiperazine-N’-2-ethansulfonic acid 
Histidine 
Hydroxybenzotriazole 
High pressure liquid 
High resolution mass spectrometry 
Heteronuclear single quantum coherence 
Inductively coupled plasma 
Infrared 
Isothermal titration calorimetry 
Coupling Constant 
Langmuir Blodgett 
Methyl 
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MeCN  
MeOH  
MF  
min  
MLV  
MP  
MW  
NEt3  
NMR  
NOESY  
NTA  
PE  
Ph  
PMT  
PPi  
pSer  
Rf  
ROESY  
rpm  
RT  
SAM  
SEC  
SUV  
TAMRA  
TBTU  
TEM  
Terpy  
TFA  
THF  
TLC  
TM 
TMR  
TRIS  
Acetonitrile 
Methanol 
Molecular formula 
Minutes 
Multilamellar vesicles 
Melting point 
Molecular weight 
Triethylamine 
Nuclear magnetic resonance 
Nuclear overhauser enhancement spectroscopy 
Nitrilotriacetic acid 
Petrol Ether (Hexanes) 
Phenyl 
Photo multiplier tube 
Pyrophosphate 
Phosphorylated serine 
Retention factor 
Rotating frame NOE spectroscopy 
Rounds per minute 
Room temperature 
Self assembled monolayer 
Size exclusion chromatography 
Small unilamellar vesicles 
Tetramethylrhodamine 
O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 
Transmission electron microscopy 
Terpyridine 
Trifluoroacetic acid 
Tetrahydrofuran 
Thin layer chromatography 
Phase transition temperature 
Tetramethylrhodamine 
Tris(hydroxymethyl)-aminomethane 
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UV  
Vis  
x  
 
Ultraviolett 
Visible 
Mole Fraction 
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